GB2423494A - Razor head including acyl isethionate surfactant dispenser - Google Patents
Razor head including acyl isethionate surfactant dispenser Download PDFInfo
- Publication number
- GB2423494A GB2423494A GB0610883A GB0610883A GB2423494A GB 2423494 A GB2423494 A GB 2423494A GB 0610883 A GB0610883 A GB 0610883A GB 0610883 A GB0610883 A GB 0610883A GB 2423494 A GB2423494 A GB 2423494A
- Authority
- GB
- United Kingdom
- Prior art keywords
- skin
- razor head
- actives
- cleansing
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 acyl isethionate Chemical compound 0.000 title claims abstract description 55
- 239000004094 surface-active agent Substances 0.000 title claims description 37
- 239000000203 mixture Substances 0.000 claims abstract description 85
- 210000002374 sebum Anatomy 0.000 claims abstract description 13
- 239000002537 cosmetic Substances 0.000 claims abstract description 12
- 230000008439 repair process Effects 0.000 claims abstract description 11
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 9
- 206010040799 Skin atrophy Diseases 0.000 claims abstract description 8
- 230000003255 anti-acne Effects 0.000 claims abstract description 8
- 230000001166 anti-perspirative effect Effects 0.000 claims abstract description 8
- 230000001153 anti-wrinkle effect Effects 0.000 claims abstract description 8
- 239000003213 antiperspirant Substances 0.000 claims abstract description 8
- 230000008591 skin barrier function Effects 0.000 claims abstract description 8
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims description 65
- 238000000034 method Methods 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 239000003795 chemical substances by application Substances 0.000 claims description 32
- 239000000344 soap Substances 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 27
- 230000009969 flowable effect Effects 0.000 claims description 19
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims description 18
- 230000003750 conditioning effect Effects 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 239000003921 oil Substances 0.000 claims description 15
- 235000019198 oils Nutrition 0.000 claims description 15
- 150000004665 fatty acids Chemical group 0.000 claims description 14
- 229920002494 Zein Polymers 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000005019 zein Substances 0.000 claims description 13
- 229940093612 zein Drugs 0.000 claims description 13
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 12
- 239000011591 potassium Substances 0.000 claims description 12
- 229910052700 potassium Inorganic materials 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 229910052708 sodium Inorganic materials 0.000 claims description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
- 230000002209 hydrophobic effect Effects 0.000 claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 206010040829 Skin discolouration Diseases 0.000 claims description 7
- 239000002002 slurry Substances 0.000 claims description 7
- 230000000475 sunscreen effect Effects 0.000 claims description 7
- 239000004909 Moisturizer Substances 0.000 claims description 6
- 229940122511 Sebum inhibitor Drugs 0.000 claims description 6
- 230000000843 anti-fungal effect Effects 0.000 claims description 6
- 230000001333 moisturizer Effects 0.000 claims description 6
- 239000004264 Petrolatum Substances 0.000 claims description 5
- 229940066842 petrolatum Drugs 0.000 claims description 5
- 235000019271 petrolatum Nutrition 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 229940121375 antifungal agent Drugs 0.000 claims description 4
- 230000036252 glycation Effects 0.000 claims description 4
- 239000003589 local anesthetic agent Substances 0.000 claims description 4
- 239000002480 mineral oil Substances 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 229940045998 sodium isethionate Drugs 0.000 claims description 4
- LADXKQRVAFSPTR-UHFFFAOYSA-M sodium;2-hydroxyethanesulfonate Chemical compound [Na+].OCCS([O-])(=O)=O LADXKQRVAFSPTR-UHFFFAOYSA-M 0.000 claims description 4
- 238000007046 ethoxylation reaction Methods 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 239000003193 general anesthetic agent Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 136
- 239000012071 phase Substances 0.000 description 131
- 238000012360 testing method Methods 0.000 description 82
- 239000000047 product Substances 0.000 description 49
- 235000002639 sodium chloride Nutrition 0.000 description 20
- 239000000463 material Substances 0.000 description 19
- 206010015150 Erythema Diseases 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 18
- 229910052782 aluminium Inorganic materials 0.000 description 16
- 231100000321 erythema Toxicity 0.000 description 16
- 230000008901 benefit Effects 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 15
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 14
- 125000002091 cationic group Chemical group 0.000 description 14
- 230000000007 visual effect Effects 0.000 description 14
- 108010055615 Zein Proteins 0.000 description 13
- 239000013543 active substance Substances 0.000 description 13
- 125000000217 alkyl group Chemical group 0.000 description 13
- 239000002585 base Substances 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 241000282372 Panthera onca Species 0.000 description 12
- 239000003599 detergent Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000002689 soil Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000010998 test method Methods 0.000 description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 9
- 210000000245 forearm Anatomy 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 235000013162 Cocos nucifera Nutrition 0.000 description 8
- 244000060011 Cocos nucifera Species 0.000 description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 8
- 239000003974 emollient agent Substances 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 239000007790 solid phase Substances 0.000 description 7
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 102000035195 Peptidases Human genes 0.000 description 6
- 206010040844 Skin exfoliation Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 235000019833 protease Nutrition 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- HAMGNFFXQJOFRZ-UHFFFAOYSA-L aluminum;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4] HAMGNFFXQJOFRZ-UHFFFAOYSA-L 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000005336 cracking Methods 0.000 description 5
- 238000004299 exfoliation Methods 0.000 description 5
- 238000001125 extrusion Methods 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 239000000155 melt Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 238000003672 processing method Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 5
- 239000000271 synthetic detergent Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 4
- 208000033694 Generalised erythema Diseases 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 4
- 125000003368 amide group Chemical group 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 230000003381 solubilizing effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 235000020238 sunflower seed Nutrition 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- 235000010215 titanium dioxide Nutrition 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- 235000002961 Aloe barbadensis Nutrition 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 3
- 235000011437 Amygdalus communis Nutrition 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 102220549062 Low molecular weight phosphotyrosine protein phosphatase_C13S_mutation Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 244000044822 Simmondsia californica Species 0.000 description 3
- 235000004433 Simmondsia californica Nutrition 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 235000011399 aloe vera Nutrition 0.000 description 3
- 229940037003 alum Drugs 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 239000001164 aluminium sulphate Substances 0.000 description 3
- 235000011128 aluminium sulphate Nutrition 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- BUACSMWVFUNQET-UHFFFAOYSA-H dialuminum;trisulfate;hydrate Chemical compound O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BUACSMWVFUNQET-UHFFFAOYSA-H 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 2
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 229910021532 Calcite Inorganic materials 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 244000025272 Persea americana Species 0.000 description 2
- 235000008673 Persea americana Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920000289 Polyquaternium Polymers 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical class [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- ZGUQGPFMMTZGBQ-UHFFFAOYSA-N [Al].[Al].[Zr] Chemical compound [Al].[Al].[Zr] ZGUQGPFMMTZGBQ-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 159000000013 aluminium salts Chemical class 0.000 description 2
- 229910000329 aluminium sulfate Inorganic materials 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 229940070761 c14-16 olefin sulfonate Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000010627 cedar oil Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- VEVFSWCSRVJBSM-HOFKKMOUSA-N ethyl 4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 VEVFSWCSRVJBSM-HOFKKMOUSA-N 0.000 description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 239000003966 growth inhibitor Substances 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000003605 opacifier Substances 0.000 description 2
- 150000002924 oxiranes Chemical class 0.000 description 2
- LQPLDXQVILYOOL-UHFFFAOYSA-I pentasodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)CC([O-])=O LQPLDXQVILYOOL-UHFFFAOYSA-I 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- NGNZTXNWCGRXKL-UHFFFAOYSA-M potassium;16-methylheptadecanoate Chemical compound [K+].CC(C)CCCCCCCCCCCCCCC([O-])=O NGNZTXNWCGRXKL-UHFFFAOYSA-M 0.000 description 2
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000008262 pumice Substances 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000019719 rose oil Nutrition 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 239000010669 rosewood oil Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000002437 shaving preparation Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229940080279 sodium cocoate Drugs 0.000 description 2
- 229940046000 sodium isostearoyl lactylate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940045870 sodium palmitate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- FRHNXUKHAUWMOQ-UHFFFAOYSA-M sodium;16-methylheptadecanoate Chemical compound [Na+].CC(C)CCCCCCCCCCCCCCC([O-])=O FRHNXUKHAUWMOQ-UHFFFAOYSA-M 0.000 description 2
- FOSNFLMXYRQNAF-UHFFFAOYSA-M sodium;2-[2-(16-methylheptadecanoyloxy)propanoyloxy]propanoate Chemical compound [Na+].CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O FOSNFLMXYRQNAF-UHFFFAOYSA-M 0.000 description 2
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- XJPHGGXFBWOHFL-QMMMGPOBSA-N (2s)-2-hydrazinyl-3-(4-hydroxyphenyl)propanoic acid Chemical compound NN[C@H](C(O)=O)CC1=CC=C(O)C=C1 XJPHGGXFBWOHFL-QMMMGPOBSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- NSSALFVIQPAIQK-FPLPWBNLSA-N (Z)-2-Nonen-1-ol Chemical compound CCCCCC\C=C/CO NSSALFVIQPAIQK-FPLPWBNLSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- BHVJSLPLFOAMEV-UHIFYLTQSA-M 20-Epibryonolic acid Natural products C([C@H]1[C@]2(C)CC3)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@]2(C)C1=C3[C@@]2(C)CC[C@H](O)C(C)(C)[C@@H]2CC1 BHVJSLPLFOAMEV-UHIFYLTQSA-M 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 239000004251 Ammonium lactate Substances 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BHVJSLPLFOAMEV-UHFFFAOYSA-N Bryonolic acid Natural products C1CC2(C)C3CC(C)(C(O)=O)CCC3(C)CCC2(C)C2=C1C1(C)CCC(O)C(C)(C)C1CC2 BHVJSLPLFOAMEV-UHFFFAOYSA-N 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 235000016904 Citrus x jambhiri Nutrition 0.000 description 1
- 244000114646 Citrus x jambhiri Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164480 Curcuma aromatica Species 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- 102000004860 Dipeptidases Human genes 0.000 description 1
- 108090001081 Dipeptidases Proteins 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 240000004282 Grewia occidentalis Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 235000008418 Hedeoma Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-O N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonic acid Chemical group CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-O 0.000 description 1
- PSFABYLDRXJYID-UHFFFAOYSA-N N-methyl-DL-serine Natural products CNC(CO)C(O)=O PSFABYLDRXJYID-UHFFFAOYSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004614 Process Aid Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 1
- 244000086363 Pterocarpus indicus Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 101000721481 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) Succinyl-diaminopimelate desuccinylase Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 235000013584 Tabebuia pallida Nutrition 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 240000002805 Triticum turgidum Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940048496 aluminum zirconium pentachlorohydrex gly Drugs 0.000 description 1
- WYANSMZYIOPJFV-UHFFFAOYSA-L aluminum;2-aminoacetic acid;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4].NCC(O)=O WYANSMZYIOPJFV-UHFFFAOYSA-L 0.000 description 1
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 1
- SJXYSRSHDPPYIU-UHFFFAOYSA-L aluminum;propane-1,2-diol;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].CC(O)CO SJXYSRSHDPPYIU-UHFFFAOYSA-L 0.000 description 1
- YAKZEVHORUHNLS-UHFFFAOYSA-K aluminum;sodium;2-hydroxypropanoate;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Na+].[Al+3].[Cl-].CC(O)C([O-])=O YAKZEVHORUHNLS-UHFFFAOYSA-K 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229940059265 ammonium lactate Drugs 0.000 description 1
- 235000019286 ammonium lactate Nutrition 0.000 description 1
- 229940051879 analgesics and antipyretics salicylic acid and derivative Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- FUQCJMSCGSVFNQ-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;tetradecanoate Chemical compound OCCNCCO.CCCCCCCCCCCCCC(O)=O FUQCJMSCGSVFNQ-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000004064 cosurfactant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- XILPPDQAWPSZIL-UHFFFAOYSA-H dialuminum;dichloride;tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].[Cl-] XILPPDQAWPSZIL-UHFFFAOYSA-H 0.000 description 1
- KNXDJTLIRRQLBE-UHFFFAOYSA-H dialuminum;propane-1,2-diol;chloride;pentahydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].CC(O)CO KNXDJTLIRRQLBE-UHFFFAOYSA-H 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- SBBWEQLNKVHYCX-UHFFFAOYSA-N ethyl 2-amino-3-(4-hydroxyphenyl)propanoate Chemical compound CCOC(=O)C(N)CC1=CC=C(O)C=C1 SBBWEQLNKVHYCX-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- ZWJINEZUASEZBH-UHFFFAOYSA-N fenamic acid Chemical class OC(=O)C1=CC=CC=C1NC1=CC=CC=C1 ZWJINEZUASEZBH-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- UHUSDOQQWJGJQS-UHFFFAOYSA-N glycerol 1,2-dioctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC UHUSDOQQWJGJQS-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000005446 heptyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- CBKLICUQYUTWQL-XWGBWKJCSA-N methyl (3s,4r)-3-methyl-1-(2-phenylethyl)-4-(n-propanoylanilino)piperidine-4-carboxylate;oxalic acid Chemical compound OC(=O)C(O)=O.CCC(=O)N([C@]1([C@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 CBKLICUQYUTWQL-XWGBWKJCSA-N 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000005599 propionic acid derivatives Chemical class 0.000 description 1
- NQLVQOSNDJXLKG-UHFFFAOYSA-N prosulfocarb Chemical compound CCCN(CCC)C(=O)SCC1=CC=CC=C1 NQLVQOSNDJXLKG-UHFFFAOYSA-N 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229940045905 sodium tallowate Drugs 0.000 description 1
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical compound OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-L tyrosinate(2-) Chemical compound [O-]C(=O)C(N)CC1=CC=C([O-])C=C1 OUYCCCASQSFEME-UHFFFAOYSA-L 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 150000003668 tyrosines Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/02—Shaving preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B26—HAND CUTTING TOOLS; CUTTING; SEVERING
- B26B—HAND-HELD CUTTING TOOLS NOT OTHERWISE PROVIDED FOR
- B26B21/00—Razors of the open or knife type; Safety razors or other shaving implements of the planing type; Hair-trimming devices involving a razor-blade; Equipment therefor
- B26B21/40—Details or accessories
- B26B21/44—Means integral with, or attached to, the razor for storing shaving-cream, styptic, or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B26—HAND CUTTING TOOLS; CUTTING; SEVERING
- B26B—HAND-HELD CUTTING TOOLS NOT OTHERWISE PROVIDED FOR
- B26B21/00—Razors of the open or knife type; Safety razors or other shaving implements of the planing type; Hair-trimming devices involving a razor-blade; Equipment therefor
- B26B21/40—Details or accessories
- B26B21/44—Means integral with, or attached to, the razor for storing shaving-cream, styptic, or the like
- B26B21/443—Lubricating strips attached to the razor head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B26—HAND CUTTING TOOLS; CUTTING; SEVERING
- B26B—HAND-HELD CUTTING TOOLS NOT OTHERWISE PROVIDED FOR
- B26B21/00—Razors of the open or knife type; Safety razors or other shaving implements of the planing type; Hair-trimming devices involving a razor-blade; Equipment therefor
- B26B21/08—Razors of the open or knife type; Safety razors or other shaving implements of the planing type; Hair-trimming devices involving a razor-blade; Equipment therefor involving changeable blades
- B26B21/14—Safety razors with one or more blades arranged transversely to the handle
- B26B21/22—Safety razors with one or more blades arranged transversely to the handle involving several blades to be used simultaneously
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mechanical Engineering (AREA)
- Engineering & Computer Science (AREA)
- Forests & Forestry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
The razor head includes at least one blade 58. A cleanser including a C8-018 acyl isethionate (hydroxyethyl suiphonate) is fed, possibly through apertures (124, figure 3), on to a first skin contacting area 54. Preferably an after shave is fed on to a second skin contacting area 70. Either composition may also contain anti-acne, anti-wrinkle, anti-skin atrophy, skin barrier repair, cosmetic soothing, tanning, lightening, antimicrobial, antiperspirant, anti-glycation, sebum control, anaesthetic or sunscreen agents. The razor head can almost simultaneously moisturise, clean and shave.
Description
J6959 (C) CT PATENT OFFICE - DEFjmir- - y - - 24234
RAZOR HEAD WITH MILD CLEANSING COMPOSITION AS A SHAVING AID
The present invention relates to a razor head suitable for personal shaving. In particular, it relates to a razor head associated with a cleansing composition that is mild to the skin and is easily manufactured.
A personal or safety razor typically includes a disposable razor cartridge mounted in a reusable handle, or a handle and a cartridge combined into a unitary disposable unit.
Most razor cartridges include a frame, at least one razor blade, and a quantity of shaving aid material attached to or held within the frame to enhance the shaving process. The shaving aid material facilitates the movement of the razor blade over the skin and/or aids in the removal in advance of the blade assembly or simultaneously with the blade assembly of hair from the skin. Prior art shaving aid materials include lubricating agents, drag-reducing agents, depilatory agents, cleansing agents, medicinal agents, and the like.
Prior art shaving aids that are also cleansing agents typically have consisted of soap and/or synthetic detergents that are either harsh to the skin, are disadvantageous to manufacture or both.
U.S. Patent No. 4,944,090 issued to Sumnall on July 31, 1990 discloses a razor head with a shaving aid sufficient to last the life of the razor without the need f or supplementary shave creams or lubricants. U.S. Patent No. 4,074,429 issued to Roberts on Feb. 21, 1978 discloses a razor assembly with a soap cake and optional water reservoir for dispensing a lubricating lather in advance of the blade. U.S. Patent No. J6959 (C) CT 6,584,690 issued to Orloff et al. on July 1, 2003 discloses a wet shaving assembly for simultaneously applying a shaving preparation and removing hair in a single step. The shaving cake used is soap and may contain optional lubricating or beneficial agents and fragrances. U.S. Patent Publication No. 2005/0011073 to Sandor et al. and published on Jan. 20, 2005 discloses a wet shaving assembly for simultaneously applying a shaving preparation and removing hair in a single step wherein the shaving cake may contain soap and/or synthetic detergents such as alkyl glyceryl sulfonate and laureth-16.
U.S. Patent No. 4,170,821 issued to Booth on Oct. 16, 1979 discloses a water soluble shaving aid incorporated in a disposable razor blade cartridge which gradually dissolves during the act of wet shaving. The shaving aid may contain a cleaning agent such as a silicon polyethylene oxide block copolymer or sodium lauryl sulfate. U.S. Patent Publication No. 2004/0181943 to Kwiecken and published on Sep. 23, 2004 discloses a shaving aid composite including exfoliating elements or material.
The solid cleansing phase of the inventive razor head under actual use conditions is expected to be more easily manufactured due its higher Kraf ft point properties in a preferred embodiment. Furthermore it would be expected to show improvements in skin irritation, skin feel and similar consumer perceived benefits such as mildness, moisturization efficiency, deposition efficiency, cleansing efficiency, and other art recognized skin benefits based on changes from the baseline for these measurements, compared to prior art razor J6959 (C) CT heads as quantified using the test methods described below and other art recognized test methods.
In one aspect of the invention, there is provided a razor head for personal shaving, including but not limited to the following: at least one blade member; a first skin engaging portion effectively positioned adjacent to said at least one blade for treating the skin of a user in advance of or simultaneously with the blade member contacting the skin of a user, the portion including and/or fluidly communicating with a mild cleansing base; and wherein the cleansing base includes at least one surfactant selected from C8 - C18 acyl isethionate(s) In another aspect of the invention, there is provided a method for simultaneously shaving and moisturizing the skin with a razor including but not limited to the steps of: 1. providing a razor head including a cleansing base comprising about 1 % to 60 % by wt. of one or more surfactants selected from C8 - C18 acyl isethionate(s) and about 1 % to 60 % by wt. of a skin conditioning agent; 2. adding sufficient water to wet the cleansing base and the skin; 3. applying the razor head to the skin; and J6959 (C) CT 4. moving the razor head across the skin to remove hair and coat the underlying skin with at least one skin conditioning agent.
Preferred embodiments of the invention will now be described by way of example with reference to the accompanying drawings wherein like figures represent like features, in which: - Fig. 1 is a top planar view showing one preferred embodiment of the razor head of the present invention; Fig. 2 is a top planar view showing a second preferred embodiment of the razor head of the present invention; - Fig. 3 is a top planar view showing a third embodiment of the razor head of the present invention; and - Fig. 4 is a top planar view showing a fourth preferred embodiment of the razor head of the present invention.
One preferred embodiment of the inventive razor head is depicted in Fig. 1. The inventive razor head 10 includes frame 12 which contains a first skin contacting portion including a cleansing phase 14 which may be a liquid or solid phase or a carrier phase saturated with a flowable cleansing phase. Also depicted in Fig. 1 is blade assembly 16 including razor blades 18 positioned in bore 20 adjacent to first skin contacting portion 14 and to wall 22.
J6959 (C) CT Suitable carrier phase material includes woven and/or nonwoven fibrous medium, sponge medium, composite medium, or like medium which releasably contains a flowable cleansing phase whereby the carrier phase is either partially or fully saturated with a flowable liquid cleansing composition. In the case of a solid phase, the first skin contacting portion 14 and/or blade assembly 16 are movably situated with respect to each other within frame 12 or within separate frames situated in close proximity to each other. This is so that as the solid cleansing phase 14 wears away with use, the cleansing phase 14, blade assembly 16 or both can be automatically or manually repositioned to maintain skin contact for some period in advance of or during the shaving process.
Any mechanism or method suitable for moving the cleansing phase or blade assembly or both relative to each other to accomplish skin contact of the cleansing phase in advance of the blade assembly or simultaneously with the blade assembly may be used, such as a mechanical drive and/or gear mechanism, a ratcheting mechanism, a bias mechanism, a lever mechanism, a pneumatic mechanism, a rigid shaft mechanism, a frictional slide mechanism, or any combination or equivalent thereof. In use, the razor head may be exposed to water so as to activate the cleansing composition, or used with no added water.
A second preferred embodiment is depicted in Fig. 2. The inventive razor head 50 includes frame 52 which holds first skin contacting portion including a cleansing phase 54 alongside one side of blade assembly 56 and second skin J6959 (C) CT contacting portion including after shave phase 70 positioned alongside the opposite side of blade assembly 56. Blade assembly 56 includes razor blades 58 positioned in bore 60 adjacent to first skin contacting portion 54 and second skin contacting portion 70. Frame 52 and bore 60 collectively separate first skin contacting portion 54 and second skin contacting portion 70. In other preferred embodiments, the skin contacting portions may be limited so as to only be coextensive with the length of the blade, and may be separated by a gap or abut each other if the first and second skin contacting portions are compatible with each other.
A third preferred embodiment of the inventive razor head is depicted in Fig. 3. The inventive razor head 100 includes frame 112 which contains a first skin contacting portion 114 having apertures 124 through which a liquid or flowable cleansing composition may be admitted onto the first skin contacting portion 114 so as to contact the skin of the user for some period while shaving. Also depicted in Fig. 3 is blade assembly 116 including razor blades 118 positioned in bore 120 adjacent to first skin contacting portion 114 and to wall 122.
In this embodiment, the flowable cleansing composition may be transported from a reservoir (not illustrated) within the razor head and/or handle or other storage container (not illustrated) via one or more conduits (not illustrated) communicating with apertures 124 by any suitable fluid transport mechanism such as capillary action, pressure differential, gravity or any combination or equivalent J6959 (C) CT thereof, or by wicking material or other equivalent solid/liquid transport system for carrying the flowable cleansing composition to the skin while shaving in advance of the blade or simultaneously with the blade.
A fourth preferred embodiment is depicted in Fig. 4. The inventive razor head 150 includes frame 152 which holds first skin contacting portion 154 having apertures 164 through which a liquid or flowable cleansing composition may be admitted onto the first skin contacting portion 164 so as to contact the skin of the user for some period while shaving, analogous to the embodiment described in Fig. 3.
First skin contacting portion 154 is situated alongside one side of blade assembly 156, and second skin contacting portion 170 is positioned alongside the opposite side of blade assembly 156. Second skin contacting portion 170 has apertures 166 through which a liquid or flowable after shave composition may be admitted onto the second skin contacting portion 170 so as to contact the skin of the user for some period after shaving analogous to the cleansing phase.
Blade assembly 156 includes razor blades 158 positioned in bore 160 adjacent to first skin contacting portion 154 and second skin contacting portion 170. Frame 152 and bore 160 collectively separate first skin contacting portion 154 and second skin contacting portion 170. In other preferred embodiments, the skin contacting portions may be limited so as to only be coextensive with the length of the blade, and may be separated by a gap or abut each other.
J6959 (C) CT In operation, the user will slide the razor across the skin whereby the first skin contacting portion contacts the skin in advance of the blade assembly or simultaneously with the blade assembly. The optional after shave phase will contact the skin after the blade assembly contacts the skin, thus providing the after shave benefit to the skin just shaven.
Analogous to the cleansing phase, the after shave phase may be a liquid or solid phase or a carrier phase saturated with a flowable phase and have the same transport characteristics discussed above for the cleansing phase.
In one aspect of the invention there is provided a razor head for personal shaving, including but not limited to the following: at least one blade member; a first skin engaging portion effectively positioned adjacent to said at least one blade for treating the skin of a user in advance of or simultaneously with the blade member contacting the skin of a user, the portion including and/or fluidly communicating with a mild cleansing base; and wherein the cleansing base includes at least one surfactant selected from C8 - C18 acyl isethionate(s), preferably having a Kraf ft point of about 20 C or greater, and preferably present in a total concentration of about 1 % to 60 % by wt. Preferably the cleansing phase has a zein value of less than 50.
Preferably the blade member and cleansing base are situated within a single frame or in a plurality of frames positioned substantially adjacent to each other.
Advantageously the razor head further includes a second skin engaging portion effectively positioned adjacent to said at least one blade member for treating the skin of a user J6959 (C) CT subsequent to and/or simultaneously with the blade member contacting the skin of a user, said portion including and/or fluidly communicating with an after shave base.
In a preferred embodiment, the inventive razor head has a cleansing phase that includes one or more hydrophillic and/or hydrophobic skin conditioning compounds in a total concentration range of about 1 % to 60 % by wt. In a preferred embodiment, the cleansing phase is in the form of a solid having a yield stress value from about 20 Kpa to 400 KPa at 25 C and 50 % RH.
Advantageously, the cleansing phase and/or the after shave phase or both contain an effective concentration of at least one compound selected from anti-acne actives, anti-wrinkle and anti-skin atrophy actives, skin barrier repair aids, cosmetic soothing aids, topical anesthetics, artificial tanning agents and accelerators, skin lightening actives, antimicrobial and antifungal actives, sunscreen actives, sebum stimulators, sebum inhibitors, antiperspirants, anti- glycation actives or mixtures thereof.
In a further preferred embodiment, the cleansing phase and/or after shave phase or both is/are in the form of a flowable liquid with a viscosity range of about 100 to 2000 cps at 25 C as measured using a rotary viscometer such as a Brookfield or Haake viscometer or the like. Preferably the flowable liquid includes potassium and/or sodium acyl isethionate, more preferably having about 1 to 10 moles of ethoxylation and most preferably being present at a concentration range of about 3 % to 15 % by weight.
J6959 (C) CT - 10 - Advantageously the skin conditioning compound is selected from polyols (such as polyethylene glycol), polyhydric alcohols, fatty acids, glyceride oil, mineral oil, petrolatum, glycerin, or blends thereof. Preferably the cleansing phase provides an aqueous slurry pH of about 4 to 8. More preferably the cleansing phase has less than about % by wt. of soluble soap.
In another aspect of the invention, there is provided a method for simultaneously shaving and moisturizing the skin with a razor including but not limited to the steps of: 1. providing a razor head including a cleansing base comprising about 1 % to 60 % by wt. of one or more surfactants selected from C8 - C18 acyl isethionate(s) and about 1 % to 60 % by wt. of a skin conditioning agent; 2. adding sufficient water to wet the cleansing base and the skin; 3. applying the razor head to the skin; and 4. moving the razor head across the skin to remove hair and coat the underlying skin with at least one skin conditioning agent.
As discussed above, the inventive razor head under actual use conditions is expected to show improvements in skin softness, skin smoothness, and similar consumer perceived benefits such as after shave feel, mildness, moisturization J6959 (C) CT - 11 - efficiency, deposition efficiency, cleansing efficiency, etc. based on changes from the baseline for these measurements using razor heads with prior art shaving aid cleansing compositions, as quantified using the test methods described below. These skin benefit parameters can also be expressed quantitatively as the ratio of the inventive razor head response to the comparative razor head response. Where the magnitude of the inventive razor head benefit improvement is expected to exceed the numerical result of the comparative razor head, the observed ratio will be greater than 1.0; i.e. greater than 1.02, 1.05, 1.07, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2.0.
Table 1 below illustrates how various properties of a preferred embodiment of the inventive razor head are expected to compare to prior art razor heads with a cleansing phase that does not contain the inventive mild, isethionate surfactants. The test methods that may be used to measure the properties are provided below. In a preferred embodiment of the invention, the after shave phase will provide skin treatment benefits as part of the shaving process without the need for separate application of an after shave preparation to the skin.
J6959 (C) CT - 12 - Table la: Inventive razor head with solid cleansing phase A' vs. Comparative Al (2) (solid phase soap razor head) Property Ratio vs. Comparative Al Mildness > I Moisturization > I Moisturizer deposition > I Softness > I Smoothness > I Inventive A: see Table 1 2Comparative Al: Schick Intuition razor with solid cleansing phase containing Sodium Palmitate, Sodium Cocoate, Sodium Isostearate, Water, Potassium Palmitate, Glycerin, Potassium Isostearate, Sodium Isostearoyl Lactylate, Sodium Coconut Alkyl Glyceryl Sulfonate Paste, Kaolin, Isostearic Acid, Sucrose Cocoate, Rosewood Oil, Almond Oil, Cedarwood Oil, Rose Oil, Titanium Dioxide, Sodium Chloride, Tocopheryl Acetate, Cocoa Butter, Tetrasodium Etidronate, Pentasodium Pentetate, Aloe Barbadensis J6959 (C) CT - 13 - Table 2a: Inventive razor head with solid cleansing phase A vs. Comparative A23 (solid phase soap razor head with added IJEA-Myristate and/or laureth 16 synthetic detergents) Property Ratio vs. Comparative A2 Mildness = I Moisturization = I Moisturizer deposition = I Softness = I Smoothness = I 3Comparative A2: Sodium Palmitate, Sodium Cocoate, Sodium Isostearate, Water, Potassium Palmitate, Glycerin, Potassium Isostearate, Sodium Isostearoyl Lactylate, Sodium Coconut Alkyl Glyceryl Sulfonate Paste, Kaolin, Isostearic Acid, Sucrose Cocoate, Rosewood Oil, Almond Oil, Cedarwood Oil, Rose Oil, Titanium Dioxide, Sodium Chloride, Tocopheryl Acetate, Cocoa Butter, Tetrasodium Etidronate, Pentasodium Pentetate, Aloe Barbadensis with added DEA-Myristate and/or Alkyl Glyceryl Sulfonate and/or laureth 16 synthetic detergents.
Surfactants are an essential component of the cleansing phase of the inventive razor head. They are compounds that have hydrophobic and hydrophilic portions that act to reduce the surface tension of the aqueous solutions they are dissolved in. Useful surfactants can include soap(s) , and non-soap anionic, nonionic, amphoteric, and cationic surfactant(s), and blends thereof in addition to the mild isethionate synthetic detergents of the present invention.
J6959 (C) CT - 14 - The cleansing phase of the inventive razor head contains C8- C18 acyl isethionate surfactants having the general formula: RC-O(O) -CH2- CH2-S03 M or (RC-O(o) -CH2-CH2-so3)2M wherein R is an alkyl group having 8 to 18 carbons, and M is a mono or divalent cation such as, for example, sodium, potassium, ammonium, calcium and magnesium or other mono- and divalent cations. Preferably the isethionates have an average iodine value of less than 20.
Krafft point is an important consideration for selecting one or more primary surfactants for both the solid and liquid or flowable form of the cleansing phase of the preferred embodment of the invention. For the solid phase, it is essential to keep the Kraf ft point of this surfactant above 20, 21, 22 or 23 C to keep the cleansing phase integrity, mush, wear, and processability under acceptable limits.
Advantageously the maximum Kraf ft point is less than about 45 C. Typically the Kraf ft point of the isethionate surfactant will be under 23, 22, 21 or 20 C for the liquid cleansing phase of the invention.
Preferably acyl isethionates used in the solid cleansing phase embodiment of the present invention are produced by a DEFI' reaction where a mixture of a C8-C18, preferably ClO J6959 (C) CT - 15 - to C15 or Cl6-C18 fatty acids (e.g., lauric and coconut acid) reacts with alkali metal isethionate as follows: RC-O(OH) + HO-CH2-CH2-S03 M - RC-O(O) -CH2-CH2-SO3M (plus residual starting materials) or RC-O(OH) + (HO-CH2- CH2-SO3)2M (RC-O(O)-CH2-CH2-S03)2M (plus residual starting materials) The reaction is advantageously conducted at a stoichiometric ratio of about 1 to 1 to 2 to 1 fatty acid to isethionate using 0.01 % to 1 %, preferably 0.1 % to 0.4 % of total reactants by weight of a catalyst (e.g., zinc oxide, zirconium oxide, zinc isethionate or any Lewis acid including sulfuric acid, p-toluene sulfonic acid, sodium bisulfite etc.) at a temperature of about 150 C to 250 C, preferably about 200 C to 250 C for about 1 to 3 hours. It is often advantageous to use a relatively small amount of the final product (produced earlier) as an emulsifying agent for the reaction mixture to help speed up the reaction. The components of the reaction may be added in any order and, although yields may be better reacting one agent before another, any order of addition is contemplated.
One surfactant advantageously used in the solid cleansing phase of a preferred embodiment of this invention is sodium cocoyl isethionate with balanced chain length for desirable lathering and processing properties. For desirable J6959 (C) CT - 16 - lathering properties, 40 % to 95 % of the acyl isethionate is C8-C14. More preferably this range is from 50 % to 90 % or 60 % to 85 %, and most preferably it is from 70 % to 75 %. However too high a concentration C8-Cl4 acyl isethionates, which have a lower Kraf ft point than e.g. C16- C18 acyl isethionates, will result in a soft product that cannot be processed effectively by an extrusion process.
Further such bars cannot be stamped properly and will have many defects. Therefore a balance is necessary between lower Kraf ft point isethionates for lather, and higher Kraf ft point isethionates for efficient extrusion and stamping processability. C16-C18 acyl isethionates are advantageously in the range of 5 % to 40% or 35%, preferably in the range of 15 % to 30 %, and most preferably in the range of 23 % to 28 % for this embodiment. The most preferred ratio of C8-C14 isethionate to C16-C18 isethionate is about 3:1. As discussed above, surfactants with lower Krafft points can be used but at very low levels as co- surfactants in the solid cleansing composition.
For the liquid or flowable cleansing phase of another preferred embodiment of the invention, the preferred component is a potassium and/or sodium salt of C8-C18, preferably C8-C14 acyl isethionates with lower Kraf ft point than are optimally found in the solid cleansing phase and with preferably 1-10 moles of ethoxylation.
The cleansing phase of the inventive razor head may contain one or more non-soap anionic detergent(s) (syndets) other than acyl isethionates useful as co-surfactants. Preferably J6959 (C) CT - 17 - the syndet(s) have a zein value of 50 or less so as to provide mildness. Zein value may be measured using the test method described below. Advantageously such non-soap anionic detergent(s) or surfactant(s) may be used from about 1, 2, 3, 5, 10, 15, 20 or 30 % by wt. to about 40, 50 or 60 % by wt.
The anionic detergent active which may be used as a co- surfactant may be aliphatic sulfonate(s), such as a primary alkane (e.g., C8-C22) sulfonate(s), primary alkane (e.g., C8- C22) disulfonate(s), C8-C22 alkene sulfonate(s), C8-C22 hydroxyalkane sulfonate(s) or alkyl glyceryl ether sulfonate(s) (AGS); or aromatic sulfonate(s) such as alkyl benzene sulfonate.
The anionic may also be alkyl sulfate(s) (e.g., C12-C18 alkyl sulfate) or alkyl ether sulfate (including alkyl glyceryl ether sulfates). Among the alkyl ether sulfate(s) are those having the formula: RO (CH2CH2O) SO3M wherein R is an alkyl or alkenyl having 8 to 18 carbons, preferably 12 to 18 carbons, n has an average value of greater than 1.0, preferably greater than 3, and M is a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium. Ammonium and sodium lauryl ether sulfates are preferred.
J6959 (C) CT - 18 - The anionic may also be alkyl sulfosuccinate(s) (including mono- and dialkyl, e.g., C6-C22 sulfosuccinate(s)), alkyl and acyl taurate(s), alkyl and acyl sarcosinate(s), sulfoacetate(s), C8-C22 alkyl phosphate(s) and phosphate(s), alkyl phosphate ester(s) and alkoxyl alkyl phosphate ester(s), acyl lactate(s), C8-C22 monoalkyl succinate(s) and maleate(s), sulphoacetate(s), and alkyl glucoside(s) and the like.
Sulfosuccinates may be monoalkyl sulfosuccinates having the formula: R4O2CCH2CH (SO3M) CO2M and amide-MEA sulfosuccinates of the formula; R4CONHCH2CH2O2CCH2CH (SO3M) CO2M wherein R4 ranges from C8-C22 alkyl and M is a solubilizing cation.
Sarcosinates are generally indicated by the formula: R1CON(CH3) CH2CO2M wherein R1 ranges from C8-C20 alkyl and M is a solubilizing cation.
J6959 (C) CT - 19 - Taurates are generally identified by formula: R2CONR3 CH2 CH2 SO3M wherein R2 ranges from C8-C20 alkyl, R3 may be H or C1-C4 alkyl and M is a solubilizing cation.
The inventive razor head has a cleansing phase that may include low levels of fatty acid soap and preferably under 30, 20, 10, 8, 5, 3, 2, or 1 % by wt. of soap to improve mildness. The term "soap" is used here in its popular sense, i.e., the alkali metal or alkanol ammonium salts of aliphatic alkane or alkene monocarboxylic acids preferably having about 12 to 22 carbon atoms, more preferably about 12 to about 18 carbon atoms. They may be further described as alkali metal carboxylates of aliphatic hydrocarbons.
Sodium, potassium, mono-, di- and tn-ethanol ammonium cations, or combinations thereof, are suitable for purposes of this invention.
In general, sodium soaps are used in the compositions of this invention, but from about 1 % to about 25 % of the soap may be potassium soaps. The soaps may contain unsaturation in accordance with commercially acceptable standards.
Excessive unsaturation is normally avoided to minimize color and odor issues.
Soaps may be made by the classic kettle boiling process or modern continuous soap manufacturing processes, wherein natural fats and oils such as tallow or coconut oil or their J6959 (C) CT - 20 - equivalents are saponified with an alkali metal hydroxide using procedures well known to those skilled in the art.
Alternatively, the soaps may be made by neutralizing fatty acids, such as lauric (C12) , myristic (C14) , palmitic (C16) or stearic (C18) acids with an alkali metal hydroxide or carbonate.
Fatty acids in this carbon number range may be added to the solid cleansing phase in a small quantity as a process aid to generate the desired level of liquid crystalline phase for acceptable processing.
One or more amphoteric surfactants may be used in this invention as a cosurfactant. Advantageously amphoteric surfactants may be used from about 1, 2 or 3 % by wt. to about 5, 6, 7, 10 or 12 % by wt. Such surfactants include at least one acid group. This may be a carboxylic or a sulphonic acid group. They include quaternary nitrogen and therefore are quaternary amido acids. They should generally include an alkyl or alkenyl group of 7 to 18 carbon atoms.
They will usually comply with an overall structural formula: R'[C(O) NH(CH2)n]mN-(R2)(R3)X-Y where R1 is alkyl or alkenyl of 7 to 18 carbon atoms, R2 and are each independently alkyl, hydroxyalkyl or carboxyalkyl of 1 to 3 carbon atoms, n is 2 to 4, m is 0 to 1, X is alkylene of 1 to 3 carbon atoms optionally substituted with hydroxyl, and Y is -C02- or -SO3J6959 (C) CT - 21 - Suitable amphoteric surfactants within the above general formula include simple betaines of formula: R1-N- (R2) (R3) CH2CO2
S
and amido betaines of formula: R1-CONH(CH2)-N- (R2) (R3)CH2C02 where n is 2 or 3.
In both formulae R1, R2 and R3 are as defined previously.
may in particular be a mixture of C12 and C14 alkyl groups derived from coconut oil so that at least half, preferably at least three quarters of the groups have 10 to 14 carbon atoms. R2 and R3 are preferably methyl.
A further possibility is that the amphoteric detergent is a sulphobetaine of formula: R1-N-(R2) (R3) (CH2)3S03 or R'CONH(CH2)mN(R2)(R3)(CH2)3SO3 where m is 2 or 3, or variants of these in which -(CH2)3S03 is replaced by -CH2C(OH) (H)CH2SO3 J6959 (C) CT - 22 - In these formulae R1, R2 and R3 are as discussed previously.
Amphoacetates and diamphoacetates are also intended to be covered in the zwitterionic and/or amphoteric compounds which are used such as e.g., sodium lauroamphoacetate, sodium cocoamphoacetate, and blends thereof, and the like.
One or more nonionic surfactants may also be used in the cleansing phaseof the inventive razor head composition of the present invention. When present, nonionic surfactants may be used at levels as low as about 0.5, 1, 2 or 3 % by wt.
and as high as about 5, 10, 15 or 20 % by wt.
The nonionics which may be used include in particularly the reaction products of compounds having a hydrophobic group and a reactive hydrogen atom, for example aliphatic alcohols, acids, amides or alkylphenols with alkylene oxides, especially ethylene oxide either alone or with propylene oxide.
Specific nonionic detergent compounds are alkyl (C6-C22) phenols ethylene oxide condensates, the condensation products of aliphatic (C8-C18) primary or secondary linear or branched alcohols with ethylene oxide, and products made by condensation of ethylene oxide with the reaction products of propylene oxide and ethylenediamine. Other so-called nonionic detergent compounds include long chain tertiary amine oxides, long chain tertiary phosphine oxides and dialkyl sulphoxide, and the like.
J6959 (C) CT - 23 - The nonionic may also be a sugar amide, such as a polysaccharide amide. Specifically, the surfactant may be one of the lactobionamjdes described in U.S. Patent No. 5,389,279 to Au et al. titled "Compositions Comprising Nonionic Glycolipid Surfactants" issued February 14, 1995, which is hereby incorporated by reference, or it may be one of the sugar aniides described in Patent No. 5,009,814 to Kelkenberg, titled "Use of N-Poly Hydroxyalkyl Fatty Acid Amides as Thickening Agents for Liquid Aqueous Surfactant Systems" issued April 23, 1991, hereby incorporated into the subject application by reference.
An optional component in compositions according to the invention is a cationic skin feel agent or polymer which may be a cationic skin conditioning agent, such as for example cationic celluloses or polyquarterium compounds.
Advantageously cationic skin feel agent(s) or polymer(s) are used from about 0.01, 0.1 or 0.2 % by wt. to about 1, 1.5 or 2.0 % by wt. Cationic cellulose is available from Amerchol Corp. (Edison, NJ, USA) in their Polymer JR (trade mark) and LR (trade mark) series of polymers, as salts of hydroxyethyl cellulose reacted with trimethyl ammonium substituted epoxide, referred to in the industry (CTFA) as Polyquaternium 10. Another type of cationic cellulose includes the polymeric quaternary ammonium salts of hydroxyethyl cellulose reacted with lauryl dimethyl ammonium-substituted epoxide, referred to in the industry (CTFA) as Polyquaternium 24. These materials are available from Amerchol Corp. (Edison, NJ, USA) under the tradename J6959 (C) CT - 24 - Polymer LM-200, and quaternary ammonium compounds such as alkyldimethylammonjum halogenides.
A particularly suitable type of cationic polysaccharide polymer that can be used is a cationic guar gum derivative, such as guar hydroxypropyltrimonjum chloride (commercially available from RhonePoulenc in their JAGUAR trademark series). Examples are JAGUAR C13S, which has a low degree of substitution of the cationic groups and high viscosity, JAGUAR C15, having a moderate degree of substitution and a low viscosity, JAGUAR C17 (high degree of substitution, high viscosity), JAGUAR C16, which is a hydroxypropylated cationic guar derivative containing a low level of substituent groups as well as cationic quaternary ammonium groups, and JAGUAR 162 which is a high transparency, medium viscosity guar having a low degree of substitution.
Particularly preferred cationic polymers are JAGUAR C13S, JAGUAR C 15, JAGUAR C 17 and JAGUAR C 16 and JAGUAR C 162, especially Jaguar C13S. Other cationic skin feel agents known in the art may be used provided that they are compatible with the inventive formulation.
Other preferred cationic compounds that are useful in the present invention include amido quaternary ammonium compounds such as quaternary ammonium propionate and lactate salts, and quaternary ammonium hydrolyzates of silk or wheat protein, and the like. Many of these compounds can be obtained as the MackinerM Amido Functional Amines, Mackalene1M Amido functional Tertiary Amine Salts, and Mackpro cationic J6959 (C) CT - 25 - protein hydrolysates from the McIntyre Group Ltd. (University Park, IL).
In a preferred embodiment of the invention having a hydrolyzed protein conditioning agent, the average molecular weight of the hydrolyzed protein is preferably about 2500.
Preferably 90 % of the hydrolyzed protein is between a molecular weight of about 1500 to about 3500. In a preferred embodiment, MACKPROTM WwP (i. e. wheat germ amido dimethylamine hydrolyzed wheat protein) is added at a concentration of 0.1 % (as is) in the bar. This results in a MACKPROTM WWP "solids" of 0.035 % in the final bar formula for this embodiment.
One or more cationic surfactants may also be used in the cleansing phase of the inventive razor head. Advantageously cationic surfactants may be used from about 0.1, 0.5 or 1.0 % by wt. to about 1.5, 2.0 or 2.5 % by wt.
Examples of cationic detergents are the quaternary ammonium compounds such as alkyldimethylammonium halogenides.
Other suitable surfactants which may be used are described in U.S. Patent No. 3,723,325 to Parran Jr. titled "Detergent Compositions Containing Particle Deposition Enhancing Agents" issued March, 27, 1973, and "Surf ace Active Agents and Detergents" (Vol. I & II) by Schwartz, Perry & Berch, both of which are also incorporated into the subject application by reference.
J6959 (C) CT - 26 - In addition, the cleansing phase of the inventive razor head may include 0 to 15 % by wt. optional ingredients as follows: perfumes; sequestering agents, such as tetrasodium ethylenediaminetetraacetae (EDTA), EHDP or mixtures in an amount of 0.01 % to 1 %, preferably 0.01 % to 0.05 %; and coloring agents, opacifiers and pearlizers such as zinc stearate, magnesium stearate, Ti02, EGMS (ethylene glycol monostearate) or Lytron 621 (Styrene/Acrylate copolymer) and the like; all of which are useful in enhancing the appearance or cosmetic properties of the product.
The compositions may further comprise preservatives such as dimethyloldimethyihydantoin (Glydant XL1000), parabens, sorbic acid etc., and the like. The compositions may also comprise coconut acyl mono- or diethanol amides as suds boosters, and strongly ionizing salts such as sodium chloride and sodium sulfate may also be used to advantage.
Antioxidants such as, for example, butylated hydroxytoluene (BHT) and the like may be used advantageously in amounts of about 0.01 % or higher if appropriate.
Skin conditioning agents also termed emollients are advantageously used in the cleansing phase of the inventive razor head. Hydrophilic emollients including humectants such as polyhydric alcohols, e.g. glycerin and propylene glycol, and the like; polyols such as the polyethylene glycols listed below, and the like and hydrophilic plant extracts may be used. Advantageously humectants may be used from about 0. 01, 0.2 or 1.0 by wt. to about 3, 5 or 10 % by wt. in the solid phase cleansing composition and up to about 5, 10, 15, 20, 25, 30, 35, 40 % or more for the liquid J6959 (C) CT - 27 - cleansing phase cleansing composition. Humectants may also confer the ability for the solid cleansing phase to retain water.
Polyox WSR-205 PEG 14M, Polyox WSR-N-60K PEG 45M, or Polyox WSR-N-750 PEG 7M.
Hydrophobic emollients may be used in the cleansing phase of the inventive razor head. Advantageously hydrophobic emollients may be used from about 5, 10 or 15 % by wt. to about 20, 25, 30, 35, 40, 45 % by wt. for the solid cleansing phase and from about 0.1, 0.5, or 1 % by wt. to about 3 5, 7, 9, 10, 15, 20, or 25 % by weight for the liquid cleansing phase.
The term "emollient" is defined as a substance which softens or improves the elasticity, appearance, and youthfulness of the skin (stratum corneum) by increasing its water content, and keeps it soft by retarding the decrease of its water content.
Useful hydrophobic emollients include the following: (a) silicone oils and modifications thereof such as linear and cyclic polydimethylsiloxanes; amino, alkyl, alkylaryl, and aryl silicone oils; (b) fats and oils including natural fats and oils such as jojoba, soybean, sunflower, rice bran, avocado, almond, olive, sesame, persic, castor, coconut, mink oils; cacao fat; beef tallow, lard; hardened oils J6959 (C) CT - 28 - obtained by hydrogenating the aforementioned oils; and synthetic mono, di and triglycerides such as myristic acid glyceride and 2-ethyihexanoic acid glyceride; (c) waxes such as carnauba, spermaceti, beeswax, lanolin, and derivatives thereof; (d) hydrophobic plant extracts; (e) hydrocarbons such as liquid paraffin, petrolatum, microcrystalline wax, ceresin, squalene, pristan and mineral oil; (f) higher fatty acids such as lauric, myristic, palmitic, stearic, behenic, oleic, linoleic, linolenic, lanolic, isostearic, arachidonic and poly unsaturated fatty acids (PUFA); (g) higher alcohols such as lauryl, cetyl, stearyl, oleyl, behenyl, cholesterol and 2-hexydecanol alcohol; (h) esters such as cetyl octanoate, myristyl lactate, cetyl lactate, isopropyl myristate, myristyl myristate, isopropyl palmitate, isopropyl adipate, butyl stearate, decyl oleate, cholesterol isostearate, glycerol monostearate, glycerol distearate, glycerol tristearate, alkyl lactate, alkyl citrate and alkyl tartrate; (i) essential oils and extracts thereof such as mentha, jasmine, camphor, white cedar, bitter orange peel, ryu, turpentine, cinnamon, bergamot, citrus unshiu, calamus, pine, lavender, bay, clove, hiba, eucalyptus, lemon, starf lower, thyme, peppermint, rose, sage, sesame, ginger, basil, juniper, lemon grass, rosemary, rosewood, avocado, grape, grapeseed, J6959 (C) CT - 29 - myrrh, cucumber, watercress, calendula, elder flower, geranium, linden blossom, amaranth, seaweed, ginko, ginseng, carrot, guarana, tea tree, jojoba, comfrey, oatmeal, cocoa, neroli, vanilla, green tea, penny royal, aloe vera, menthol, cineole, eugenol, citral, citronelle, borneol, linalool, geraniol, evening primrose, camphor, thymol, spirantol, penene, sweet almond, rose, cedarwood, limonene and terpenoid oils; and (j) mixtures of any of the foregoing components, and the like.
Preferred hydrophobic emollient moisturizing agents are selected from fatty acids, di- and triglyceride oils, mineral oils, petrolatum, and mixtures thereof; with fatty acids being most preferred.
The Kraf ft point of a surfactant is defined as the temperature (or more precisely, the narrow temperature range) above which the solubility of a surfactant rises sharply. In other words, the Kraf ft point of a surfactant solution is the temperature below which the surfactant falls out of solution at concentrations above the critcal micelle concentration or CMC. Below the Kraf ft point the surfactant is incapable of solubilization and formulations become unstable. At this temperature the solubility of the surfactant becomes equal to the critical micelle concentration. it may be determined by locating the abrupt change in slope of a graph of the logarithm of the solubility against temperature or l/T or can be rapidly estimated using the rapid estimation procedure described below.
J6959 (C) CT - 30 - The cleansing and/or after shave phase of the inventive razor head may contain particles that are greater than 50, 60, 70, 80, 90 or 100 microns in average diameter (or major axis length) that help remove dry skin. Not being bound by theory, the degree of exfoliation depends on the size and morphology of the particles. Large and rough particles are usually very harsh and irritating. Very small particles may not serve as effective exfoliants. Such exfoliants used in the art include natural minerals such as silica, talc, calcite, pumice, tricalcium phosphate; seeds such as rice, apricot seeds, etc; crushed shells such as almond and walnut shells; oatmeal; polymers such as polyethylene and polypropylene beads, flower petals and leaves; microcrystalline wax beads; jojoba ester beads, and the like.
These exfoliants come in a variety of particle sizes and morphology ranging from micron sized to a few mm. They also have a range of hardness. Some examples are given in table A below.
Table A
Material Hardness (Mohs) Talc I Calcite 3 Pumice 4-6 Walnut Shells 3-4 Dolomite 4 Polyethylene J6959 (C) CT - 31 - Advantageously, optional active agents other than skin conditioning agents defined above may be added to the cleansing phase and/or after shave phase of the inventive razor head. These active ingredients may be advantageously selected from bactericides, vitamins, anti-acne actives; anti-wrinkle, anti-skin atrophy and skin repair actives; skin barrier repair actives; non-steroidal cosmetic soothing actives; artificial tanning agents and accelerators; skin lightening actives; sunscreen actives; sebum stimulators; sebum inhibitors; antiperspirants, anti- oxidants; protease inhibitors; skin tightening agents; anti-itch ingredients; hair growth inhibitors; 5-alpha reductase inhibitors; desquamating enzyme enhancers; anti-glycation agents; or mixtures thereof; and the like.
These active agents may be selected from water-soluble active agents, oil-soluble active agents, pharmaceutically- acceptable salts and mixtures thereof. The term "active agent" as used herein means personal care actives which can be used to deliver a benefit to the skin and/or hair and which generally are not used to confer a skin conditioning benefit, such are delivered by emollients as defined above.
The term "safe and effective amount", as used herein, means an amount of active agent high enough to modify the condition to be treated or to deliver the desired skin care benefit, but low enough to avoid serious side effects. The term "benefit," as used herein, means the therapeutic, prophylactic, and/or chronic benefits associated with treating a particular condition with one or more of the active agents described herein. What is a safe and J6959 (C) CT - 32 - effective amount of the active agent(s) will vary with the specific active agent, the ability of the active to penetrate through the skin, the age, health condition, and skin condition of the user, and other like factors.
Preferably the compositions of the present invention comprise from about 0.0001 % to 50 %, more preferably from about 0.05 % to 25 %, even more preferably about 0.1 % to 10 %, and most preferably about 0.1 % to 5 %, by weight of the active agent component (s) A wide variety of active agent ingredients are useful herein and include those selected from anti-acne actives, anti- wrinkle and anti-skin atrophy actives, skin barrier repair aids, cosmetic soothing aids, topical anesthetics, artificial tanning agents and accelerators, skin lightening actives, antimicrobial and antifungal actives, sunscreen actives, sebum stimulators, sebum inhibitors, anti- glycation actives and mixtures thereof and the like.
Anti-acne actives can be effective in treating acne vulgaris, a chronic disorder of the pilosebaceous follicles.
Non-limiting examples of useful anti-acne actives include the keratolytics such as salicylic acid (o-hydroxybenzoic acid), derivatives of salicylic acid such as 5-octanoyl salicylic acid and 4 methoxysalicylic acid, and resorcinol; retinoids such as retinoic acid and its derivatives (e.g., cis and trans); sulfur-containing D and L amino acids and their derivatives and salts, particularly their N-acetyl derivatives, mixtures thereof and the like.
J6959 (C) CT - 33 - Anti-microbial and anti-fungal actives can be effective to prevent the proliferation and growth of bacteria and fungi, especially in the after shave phase of the invention. Non- limiting examples of anti-microbial and anti-fungal actives include alum, boric acid, b-lactam drugs, quinolone drugs, ciprofloxacin, norfloxacin, tetracycline, erythromycin, amikacin, 2,4,4' -trichloro-2 -hydroxy diphenyl ether, 3,4,4 -Trichiorocarbanilide (triclocarban), phenoxyethanol, 2,4,4 -Trichloro-2 -Hydroxy Diphenyl Ether (triclosan); and mixtures thereof, and the like.
Anti-wrinkle, anti-skin atrophy and skin repair actives can be effective in replenishing or rejuvenating the epidermal layer. These actives generally provide these desirable skin care benefits by promoting or maintaining the natural process of desquamation. Non-limiting examples of anti- wrinkle and anti-skin atrophy actives include vitamins, minerals, and skin nutrients such as milk, vitamins A, E, and K; vitamin alkyl esters, including vitamin C alkyl esters; magnesium, calcium, copper, zinc and other metallic components; retinoic acid and its derivatives (e.g., cis and trans); retinal; retinol; retinyl esters such as retinyl acetate, retinyl palmitate, and retinyl propionate; vitamin B3 compounds (such as niacinamide and nicotinic acid), alpha hydroxy acids, beta hydroxy acids, e.g. salicylic acid and derivatives thereof (such as 5-octanoyl salicylic acid, heptyloxy 4 salicylic acid, and 4-methoxy salicylic acid) and mixtures thereof, and the like.
J6959 (C) CT - 34 - Skin barrier repair actives are those skin care actives which can help repair and replenish the natural moisture barrier function of the epidermis. Non-limiting examples of skin barrier repair actives include lipids such as cholesterol, ceramides, sucrose esters and pseudo- ceramides as described in European Patent Specification No. 556,957; ascorbic acid; biotin; biotin esters; phospholipids, and mixtures thereof, and the like.
Non-steroidal cosmetic soothing actives can be effective in preventing or treating inflammation of the skin. The soothing active enhances the skin appearance benefits of the present invention, e.g., such agents contribute to a more uniform and acceptable skin tone or color. Non- limiting examples of cosmetic soothing agents include the following categories: propionic acid derivatives; acetic acid derivatives; fenamic acid derivatives; mixtures thereof and the like. Many of these cosmetic soothing actives are described in U.S. Pat. No. 4,985,459 to Sunshine et al., issued Jan. 15, 1991, incorporated by reference herein in its entirety.
Artificial tanning actives can help in simulating a natural suntan by increasing melanin in the skin or by producing the appearance of increased melanin in the skin. Non-limiting examples of artificial tanning agents and accelerators include dihydroxyacetaone; tyrosine; tyrosine esters such as ethyl tyrosinate and glucose tyrosinate; and mixtures thereof, and the like.
J6959 (C) CT - 35 - Skin lightening actives can actually decrease the amount of melanin in the skin or provide such an effect by other mechanisms. Non-limiting examples of skin lightening actives useful herein include aloe extract, aipha-glyceryl- L-ascorbic acid, aminotyrosine, ammonium lactate, glycolic acid, hydroquinone, 4 hydroxyanisole, and mixtures thereof, and the like.
Also useful herein are sunscreen actives. A wide variety of sunscreen agents are described in U.S. Pat. No. 5,087,445, to Haffey et al., issued Feb. 11, 1992; U.S. Pat. No. 5,073,372, to Turner et al., issued Dec. 17, 1991; U.S. Pat. No. 5,073,371, to Turner et al. issued Dec. 17, 1991; and Segarin, et al., at Chapter VIII, pages 189 et seq., of Cosmetics Science and Technology, all of which are incorporated herein by reference in their entirety. Non- limiting examples of sunscreens which are useful in the compositions of the present invention are those selected from octyl methoxyl cinnamate (Parsol MCX) and butyl methoxy benzoylmethane (Parsol 1789), 2-ethylhexyl p- methoxycinnamate, 2-ethylhexyl N,N-dimethyl-p-aminobenzoate, p- aminobenzoic acid, 2-phenylbenzimidazole-s-sulfonic acid, oxybenzone, and mixtures thereof, and the like.
Sebum stimulators can increase the production of sebum by the sebaceous glands. Non-limiting examples of sebum stimulating actives include bryonolic acid, dehydroetiandrosterone (DHEA), orizanol, and mixtures thereof, and the like.
J6959 (C) CT - 36 - Sebum inhibitors can decrease the production of sebum by the sebaceous glands. Non-limiting examples of useful sebum inhibiting actives include aluminum hydroxy chloride, corticosteroids, dehydroacetic acid and its salts, S dichlorophenyl imidazoldioxolan (available from Elubiol), and mixtures thereof, and the like.
Optionally, other sebum inhibitory or antiperspirant astringent salts are included in the cleansing composition of the present invention. The astringent salts may be inorganic or organic salts of aluminum, zirconium, zinc and mixtures thereof. Preferably, the astringent salts are employed herein in particulate form, i.e., hydrophilic porous particles, of less than about 100 microns in size, preferably about 3 microns to about 10 microns in size. Salts useful as astringents or as components of astringent aluminum complexes include aluminum hydroxide, aluminum halides, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides and mixtures of these salt materials.
Aluminum salts of this type include aluminum chloride and the aluminum hydroxyhalides having the general formula Al2 (OH)Q-XH2Q where is chlorine, bromine or iodine, where x is 2 to 5 and x+ y = 6 and x and y do not need to be integers; and where X is about 1 to 6. For example, aluminum chiorohydrate, having the formula [A12(OH)5Cl]- XH2O, is preferred, due to its ready commercial availability and relatively low cost.
Several types of complexes utilizing the above astringent salts are known in the antiperspirant art. For example, J6959 (C) CT - 37 - U.S. Pat. No. 3,792,068 (Luedders et al.), discloses complexes of aluminum, zirconium and amino acids such as glycine. Complexes reported therein and similar structures are commonly known as ZAG. The ZAG complexes ordinarily have an Al:Zr ratio of from about 1.67 to 12.5 and a Metal:Cl ratio of from about 0.73 to 1. 93. The preferred amino acid for preparing such ZAG-type complexes is glycine of the formula CH2(NH2)COOH. Spherical ZAG, with particle size 1 to 100 microns, is especially preferred.
More specifically, the following is a list of astringent salts which may be useful for the present invention and which have approved listings under the United States Food & Drug Administration, Federal Register. They include aluminum chloride, aluminum chiorohydrate, aluminum chiorohydrex, aluminum chiorohydrex PEG, aluminum chlorohydrex PG, aluminum dichlorohydrate, aluminum dichiorohydrex PEG, aluminum dichlorohydrex PG, aluminum sesquichiorohydrate, aluminum sesquichiorohydrex PEG, aluminum sesquichlorohydrex PG, aluminum sulfate, aluminum zirconium octachlorohydrate, aluminum zirconium octachiorohydrex GLY (abbreviation for glycine), aluminum zirconium pentachlorohydrate, aluminum zirconium pentachlorohydrex GLY, aluminum zirconium tetrachlorohydrate, aluminum zirconium trichiorohydrate, aluminum zirconium tetrachlorohydrate GLY, and aluminum zirconium trichlorohydrate GLY.
Also suitable are: potassium aluminium sulphate, also known as alum KA1(S04)2l2H2o), aluminium undecylenoyl collagen amino acid, sodium aluminium lactate+aluminium sulphate J6959 (C) CT - 38 - Al2 (SO4) 3+Na2HA1 (OOCCHOHCH3)2- (OH) 6), sodium aluminium chlorohydroxylactate, aluminium bromohydrate (A12Br(OH) nH2O), aluminium chloride (A1C136H20), complexes of zinc salt and of sodium salt, complexes of lanthanum and cerium, and the aluminium salt of lipoamino acids (R-CO-NH-CHR'-CO-OA1-(OH)2 with R=C6/Cll and R' =amino acid).
Preferably, the antiperspirant is an aluminium salt and, more preferably, it is chosen from potassium aluminium sulphate (alum) and aluminium chiorohydrate. Amounts of the active astringent salt may range from about 0.000001 % to about 20 %, preferably from about 0.10 % to about 18 %, more preferably about 1 % to about 15 %, and optimally about 2 % to about 3 % by weight of the cleansing composition.
Aluminum chiorohydrate, referred to herein in shortened form as ACH, is the most preferred astringent salt for the purposes of the present invention, due to its wide commercial availability and relatively low cost.
Also useful as actives in the present invention are protease inhibitors. Protease inhibitors can be divided into two general classes: the proteinases and the peptidases.
Proteinases act on specific interior peptide bonds of proteins, and peptidases act on peptide bonds adjacent to a free amino or carboxyl group on the end of a protein and thus cleave the protein from the outside. The protease inhibitors suitable for use in the present invention include, but are not limited to, proteinases such as serine proteases, metalloproteases, cysteine proteases, and aspartyl protease, and peptidases, such as carboxypepidases, J6959 (C) CT - 39 - dipeptidases and aminopepidases, and mixtures thereof and the like.
Other useful active ingredients in the present invention are skin tightening agents. Non-limiting examples of skin tightening agents which are useful in the compositions of the present invention include monomers which can bind a polymer to the skin such as terpolymers of vinylpyrrolidone, (meth)acrylic acid and a hydrophobic monomer comprised of long chain alkyl (meth)acrylates, and mixtures thereof, and the like.
Active ingredients in the present invention may also include anti-itch ingredients. Suitable examples of anti-itch ingredients which are useful in the compositions of the present invention include hydrocortisone, methdilizine and trimeprazine, mixtures thereof, and the like.
Non-limiting examples of hair growth inhibitors which are useful in the compositions of the present invention include 17 beta estradiol, anti-angiogenic steroids, curcuma extract, cycloxygenase inhibitors, evening primrose oil, linoleic acid and the like. Suitable 5-alpha reductase inhibitors include ethynylestradiol, genistine and mixtures thereof, and the like.
Non-limiting examples of desquamating enzyme enhancers which are useful in the compositions of the present invention include alanine, aspartic acid, N methyl serine, serine, trimethyl glycine, mixtures thereof, and the like.
J6959 (C) CT - 40 - A non-limiting example of an anti-glycation agent which is useful in the compositions of the present invention would be Amadorine (available from Barnet Products Distributor), and the like.
EXANPLES
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "about".
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated. Physical test methods are described below.
Example 1
Useful examples of solid cleansing components for the razor head A - D according to the present invention may be prepared as shown in table 1 using the extrusion and stamping processing methods given below.
Table 1. Inventive solid cleansing compositions J6959 (C) CT - 41 Ingredients A B C D Sodium cocyl isethionate 45 45 49.5 50 Bentonite 5 Starch 5 PolymerJR(1) 0.5 Sodium Isethionate 10 10 10 10 Stearic acid 23 23 23 23 Coco betaine 3 3 3 3 82/18 tallow/coco Soap 4 4 4 4 Preservatives/Opacifiers 0.5 0.5 0.5 0.5 Sodium Stearate 1.5 1.5 1.5 1.5 Coconut fatty acid 2 2 2 2 Perfume I I I I Water 5 5 5 5 Total 100 100 100 100 (1) Amerchol Corp. (Edison, NJ)
Example 2
Useful examples of solid cleansing components for the razor head E - H according to the present invention may be prepared as shown in table 2 using the extrusion and stamping processing methods given below: J6959 (C) CT - 42 - Table 2. Inventive solid cleansing compositions Ingredients E F G H SCI 35.5 32.5 29.5 37 Alfa C14-16 Olefin Sulfonate 3 3 3 Starch 5 Kaolin 5 Sodium Lauryl Sulfate 2.5 Coco sulfosuccinate 5 Stearic Acid 25 20 25 20 Sodium Stearate 11 10 10 10 Titanium Dioxide 0.5 0.5 0.5 0.5 82/18 Coco/Tallow Soap 13 15 15 15 Sodium Isethionate 5 5 5 5 Water 6 6 6 6 Perfume I I I I J6959 (C) CT - 43 -
Example 3
A useful solid cleansing component for the razor head I - L according tothe present invention may be prepared as shown in table 3 using the melt cast processing methods given below: Table 3 Inventive melt cast solid cleansing compositions Ingredients I J K L Sodium Cocoyl Isethionate 25 23.81 22.73 21.74 Alpha C14-16 Olefin Sulfonate 9 8.57 8.18 7.83 SLES (2E0) 9 8.57 8.18 7.83 Propylene Glycol 7 6.67 6.36 6.09 Glycerin 7 6.67 6.36 6.09 12- Hydroxystearic Acid 14 13.33 12.73 12.17 Lauryl Alcohol 4.76 9.09 13. 04 Sunflower Seed Oil 25 23.81 22.73 21.74 Water 4 3.81 3.64 3.47 Total 100 100 100 100
Example 4
The mildness of solid cleansing composition M for the inventive razor head prepared from the formula shown in table 4 below was compared to comparative case 1A described in table la according to the Flex wash method described below (with eleven panellists) . The inventive composition was found to be substantially milder than the Comparative case where the average scores were found to be 0.23 for the Inventive case vs. 0.62 for the Comparative case.
J6959 (C) CT - 44 - Composition M was prepared via the melt cast method described below.
Table 4. Inventive solid cleansing composition M
_______________________________________________________
Components M Sodium Cocoyl Isethionate 21.74 Stearic acid 8.00 Glycerin 4. 00 Propylene Glycol 4.00 SLES-2E0 70 mole % 4.00 Sodium Hydroxide 1.30 12Hydroxystearic Acid 9.00 Alpha Olefin Sulfonate (C14-C18) 3.00 Cocoamidopropyl Betaine 6.00 Titanium Dioxide 1.18 Stearin (C16-C18 Triglyceride) 4.00 Sunflower Seed Oil 16.00 Petrolatum 1.00 Fragrance 1. 00 Preservatives 0.04 Coconut Acid 2.43 Sodium Tallowate 2.74 Sodium Isethionate 2.01 Water 5.13 Sodium Stearate 1.20 Cocamidopropyl Betaine 2. 04 Sodium Chloride 0.19 Total 100.0 J6959 (C) CT - 45 -
Example 5
Useful liquid cleansing compositions for the razor head 0 - Q according to the present invention, compared to a comparative liquid cleansing composition N, may be prepared as shown in table 5 using the liquid processing method given below:
Table 5
N 0 P Q Ingredients Comp. mv. mv. mv.
Water 55.2 50.4 50.3 50.2 Sodium Laureth Sulfate 15.0 15.0 10.0 5.0 Potassium Cocoyl lsethionate 5.0 10.0 15.0 Cocoamidopropyl betaine 6.0 6. 0 6.0 6.0 Sodium chloride 0.5 0.5 0.5 0.5 Ethylene glycol monostearate 1. 5 1.5 1.5 1.5 Perfume 1.0 1.0 1.0 1.0 Cationic guar polymer 0.8 0.6 0.7 0. 8 Humectants (such as glycerin) 20.0 20.0 20.0 20.0 Total 100.0 100.0 100. 0 100.0 Processing method Solid cleansing compositions A - L may be made by the following method.
The acyl isethionates may be made as follows. Sufficient amounts of coconut or other fatty acid and isethionate are combined in a vessel with a Lewis acid catalyst and heated J6959 (C) CT - 46 - to temperatures greater than 23 C to promote esterification.
Once the required conversion is met, a vacuum is applied to the heated vessel so that any excess and unreacted fatty acid may be removed. The material may then be left to solidify or flashcooled into a mixer to begin the solid cleansing phase processing, described below.
Extruded bar process Stearic acid is melted in a sigma or equivalent mixer.
Approx. 25 % solution of sodium hydroxide is used for in- situ generation of sodium stearate. Enough time is provided to dissolve sodium stearate by heating the mass to about 120 C with continuous mixing. Once sodium stearate is dissolved, then the acyl isethionate such as sodium cocoyl isethionate is added and mixed. After that the rest of the ingredients are added and the moisture is reduced to about 5 % by wt. via conventional dehydration techniques. The blend is then cooled and solidified in a spray dryer or a chill roll. The chips are then mixed with fragrance and the skin conditioning and/or skin active agent and optionally triglyceride oil is blended in a chip mixer for about 5-10 minutes. This is followed by extrusion and stamping into the desired shape. The stamped solid composition shape is inserted in the razor head.
Melt Cast process The melt cast solid cleansing phase for the inventive razor head may be formulated depending on the melt properties of the particular blend used. In this case all the bar J6959 (C) CT - 47 ingredients, including exfoliants, are blended until uniform and finally at a temperature sufficient to render the blend flowable poured into a mold. The blend is then allowed to solidify under ambient or accelerated cooling conditions (such as refrigeration and the like) Composition M is made by melt cast route. First 12- hydroxystearic acid is melted, then all the liquid components are added in the mixer except fragrance and sunflower seed oil. The mixer blend is heated to about 110 C, and the acyl isethionate such as sodium cocoyl isethionate with the other additives are slowly dissolved.
The homogeneous liquid is cooled to about 90 C and optional skin conditioners such as sunflower seed oil are added.
Perfume is added at about 75 C and the melt is poured in the specified frame in the shaving device, and allowed to cool until hard.
Liquid cleansing phase process The liquid or flowable cleansing phase for the inventive razor head may be formulated by blending the cleansing phase ingredients using any suitable blending technology until the composition is uniform, and the ingredients are dispersed or dissolved and adjusting the viscosity of the cleansing phase so that it is compatible with the liquid or flowable composition delivery system for the razor head. Appropriate mixing temperature can be 80 C, with the addition of perfume at less than 40 C. An example of a suitable mixer is IKA Labortechnik RW2O. Advantageously the viscosity is kept below 2000 cps, more preferably below 1000 cps and most J6959 (C) CT - 48 - preferably below 600 cps measured at 25 C using a Brookfield or Haake viscometer or any other suitable viscosity measurement method.
DESCRIPTION OF TEST METHODS
Methods of testing One or more of the following tests can be used to characterize the cleansing phase of the inventive razor head and compare it to the cleansing phase of comparative razor heads.
a) Mildness test i) FOREARM CONTROLLED APPLICATION TEST (FCAT) CLINICAL
TEST METHODOLOGY
In this test the cleansing phase is tested outside of the razor head. This controlled washing test is similar to that described by Ertel et al (A forearm controlled application technique for estimating the relative mildness of personal cleansing products, J. Soc. Cosmet. Chem., 46, 67 (1995)).
Subjects report to the testing facility for the conditioning phase of the study, which consists of using an assigned marketed personal washing cleanser for general use at home, up to four days prior to start of the product application phase. On Day 1 of the product application phase, a visual assessment J6959 (C) CT - 49 - is made to determine subject qualification.
Subjects must have dryness scores >1.0 and erythema scores >0.5, and be free of cuts and abrasions on or near the test sites to be included in the product application phase. Subjects who qualify to enter the product application phase will then be instructed to discontinue the use of the conditioning product and any other skin care products on their inner forearms, with the exception of the skin cleansing test formulations that are applied during the wash sessions.
Qualified subjects will then have four 3.0 cm diameter (round) evaluation sites marked on each of the forearms using a skin safe pen (a total of eight sites) . Visual evaluations for erythema and dryness will be conducted immediately prior to the first wash in each session and again in the afternoon of the final day (Day 5).
Washing Procedure for Solid Cleansing Phase Products 1. Both arms are washed simultaneously. Test sites are treated in a sequential manner starting with the site closest to the flex area, ending with the site proximal to the wrist.
2. The sites closest to the flex area of the inner forearm of both the right and left arm are moistened with warm water (90 -100 F.).
J6959 (C) CT - 50 - 3. A moistened Massljnn towel is rubbed in a circular motion on a wetted test bar for approximately 6 seconds by study personnel which will result in 0.2- 0.5 g of product to be dispensed.
4. The site is washed with the designated product for seconds followed by a 90 second lather retention phase.
5. The above procedure (1-4) is then repeated for each of the test sites. Sites are then be rinsed (e.g. using a temperature of 35 C) for fifteen seconds and patted dry.
6. Upon completion the entire procedure is repeated (two washes/session) For liquid cleansing phase products, a technician will prepare liquid products just prior to the wash session by dispensing between 0.1 g and 0.5 g of product either directly onto the skin or a moistened Maslinn towel, or an alternative application material. The washing procedure outlined above will then be used.
Evaluation Methods Baseline visual assessments are made prior to the start of the product application phase, and immediately before each wash session thereafter, to evaluate dryness and erythema. The final visual evaluation is conducted on the afternoon of the final day.
J6959 (C) CT - 51 - The 0-6 grading scale shown in Table B is used to assess the test sites for dryness and erythema. To maintain the evaluator's blindness to product assignment, visual assessments are conducted in a separate area away from the product application area.
TABLE B Eythema and Dryness grading scale Grade Erythema Dryness 0 None None 1.0 Barely perceptible Patches of slight powderiness and redness occasional patches of small scales may be seen. Distribution generalized.
2.0 Slight redness Generalized slight powderiness. Early cracking or occasional small lifting scales may be present.
3.0 Moderate redness Generalized moderate powderiness and/or heavy cracking and lifting scales.
4.0 Heavy or substantial Generalized heavy powderiness and/or redness heavy cracking and lifting scales.
5.0 Extreme redness Generalized high cracking and lifting scales. Powderiness may be present but not prominent. May see bleeding cracks.
6.0 Severe redness Generalized severe cracking.
Bleeding cracks. Bleeding cracks may be present. Scales large, may be beginning to disappear.
J6959 (C) CT - 52 - Instrumental readings are taken on the first (baseline) and final day of the study.
Mildness of test product is calculated as 1/ (mean change in dryness at end of the study) In addition to visual evaluation, instrumental assessments of the treated sites will be conducted using an evaporimeter and skin conductance meter as described in the reference above.
ii) Patch testing 48 hr continuous or 14 day cumulative insult patch test: In the 48 hr patch test 5 % to 15 % solution/slurry of the product is applied onto the upper arm/back of the subject using a standard cotton pad. Irritation response is recorded for up to 24 hrs after removal of the patch. In the 14 day cumulative test a 5 % to 15 % solution/slurry of the product is applied repeatedly every 24 hrs for 14 days. Irritation response is recorded for up to 24 hrs after removal of patch.
Mildness of test product is evaluated as 1/ (mean erythema at 24 hr after final patch removal) b) Moisturization test In this test the cleansing phase is tested outside of the razor head. Each outer, lower leg of a test subject will be divided into three sites, 6.35 x 6.35 cm (2.5 x J6959 (C) CT - 53 - 2.5 inch) squares (upper, middle and lower) for a total of 6 test sites per subject. One or two of the sites will be untreated, and will be included in the randomization of products. A technician will treat the sites once or twice with the designated amount of test material for 10 seconds. Cleansing products will remain on the test sites for a maximum of 90 seconds. Sites will be rinsed for 30 seconds each (e.g. using a temperature of 35 C), ensuring that the test material from one site does not contaminate another site. After rinsing, the test sites are gently dried with a paper towel. The application consists of dosing with up to 5 different test cleansing phase materials on the designated sites, one material per test site, and one or two untreated sites. The study personnel will perform the following wash procedure.
Test Phase: Visual Evaluation The scale as shown in Table C will be used to assess the test sites for dryness.
J6959 (C) CT - 54 -
Table C
Grade Dryness Scale Erythema Scale 0.0 No dryness No erythema 0.5 Perceptible dryness, fine white lines 1.0 Fine dry lines, white powdery look and/or Mild erythema some uplifting flakes, on less than 30 % of the test site 1.5 More uniform flaking, covering 30 % to 50 % of the test site 2.0 Uniform, marked flaking covering more Moderate than 50 % of the test site area and/or confluent isolated scaling erythema 2.5 Slight to moderate scaling 3.0 Moderate to severe scaling with some Marked uplifting of the scales erythema 3.5 Severe scaling and/or slight fissuring 4.0 Severe scaling and severe fissuring Deep erythema Baseline visual assessments will be made prior to the start of the product application phase, and thereafter immediately before each of the instrumental assessments, to evaluate skin dryness and erythema. One trained evaluator will conduct all visual evaluations during the product application phase. The evaluator will examine both lower legs with the aid of an illuminated magnifying lamp with a 3 diopter lens and a shadow-free circular cool white fluorescent light source.
J6959 (C) CT - 55 - Instrumental Assessment All instrumental evaluations will be taken following a 30 minute acclimation period. The indoor humidity and temperature data will be recorded and included in the final report. Instrumental measurements may be taken at some or all of the following time points: 0, 1, 2, 4, 6, 8 and 24 hours after product application. Instruments to be used with this protocol include: ServoMed Evaporimeter with EP1 or EP2 probe, Corneometer CM820, the Skicon Skin Hygrometer with the MT-8C probe, and the Moisture Checker. The room temperature will be maintained at 68 to 77 F and 30 % to 40 % Relative Humidity.
Moisturization is defined as mean change from baseline of (visual dryness or skin hydration).
c) Moisturizer Deposition test In this test the cleansing phase is tested outside of the razor head. Pre-condition the subject's skin (arms/legs) with non-moisturizer containing cleansing phase product for up to 2 days prior to testing. A baseline extraction is performed to estimate level of moisturizer (e.g. fatty acids) present on the skin prior to product application.
Controlled single application of product to skin (arms or legs) is made. For wash, the cleansing phase is rubbed on skin for 30 secs and the lather left on for 90 secs, rinsed for 30 secs (e.g. using a temperature of 35 C) then gently pat dry. Following this, the site is extracted using a suitable solvent (IPA)/methanol 1:1).
J6959 (C) CT - 56 - The extraction is performed as follows. A glass cup (3cm diameter) is placed on the skin. 3 mls of solvent is placed into this, and gently stirred with a glass rod for 2 minutes. The solvent is removed with a pipette. This step is repeated with a fresh 3 mis of solvent, to collect a total of 6 mls extract. The extracts are analyzed for stearic acid/palmitic acid content using either LC/MS or GC/MS, or the like.
d) Skin abrasiveness test In this test the cleansing phase is tested outside of the razor head. Skin abrasiveness is defined as consumer rated response of abrasivity on a 0-9 scale (0 means no abrasion, 10 is abrasivity caused by a pouf (i.e. a showering implement composed of thin plastic filaments, see also e.g. US Patent No. 5,650,384 to Gordon et al.).
This test is performed with 50 untrained consumers. They are asked to rate the abrasiveness of the test product on a 0-9 point scale. The data is normalized based on their response to a bar with no exfoliants which is assigned a value of zero and a pouf that is assigned a value of 9.
The test products are applied to the flex area of the forearm by wetting the bar and rubbing back and forth 10- times.
J6959 (C) CT - 57 - e) Cleansing efficacy test In this test the cleansing phase is tested outside of the razor head. Model dirt (sebum/makeup - e.g. lipstick or mascara) is applied to a designated area on the forearm/face. The site is washed with the cleansing phase product. For wash, the bar is rubbed on skin for 1 minute, rinsed for 30 secs (e.g. using a temperature of 35 C), and gently pat dry. Amount of soil/makeup removed is estimated from the difference in the chromammeter readings using e.g. a Minolta Chromameter , Model CM 2002 taken before and after wash. Alternately, high magnification digital mages are collected and analyzed using Optimas software to quantitate the amount of soil/makeup removed during the wash.
Make Up Application Make up will be applied to the 3.5 x 2.5 cm marked area on the inner side of the forearms in the manner consistent with its normal use. Cosmetic products are to be applied in a standardized way to ensure that approximately equal weights of make-up are transferred and that coverage of the test area is uniform. The application standards for the makeups are: 1.) Liquid make-up - 20 l pipette to the site and spread uniformly with gloved index finger.
2.) Lipstick - Three overlapping swipes.
3.) Eye Color Stick - Three overlapping swipes.
J6959 (C) CT - 58 - 4.) Mascara - spread uniformly using spatula for even coverage.
Soil Application Soils will be applied to the 3.5 x 2.5 cm marked area on the inner side of the forearms in the manner described below and is specific to each individual study if soils are being used. The application techniques for the soils are: 1.) Grease - 0.25g - 1.5g. will be applied.
2.) Food - 0.25g - 1.5g. will be applied.
3.) Protein - 0.25g - 1.5g. will be applied.
Product Testing Baseline measurements will be performed using the Minolta Chromameter CM-2002. Make-up or soil will then be applied to the delineated test sites as described above. Chromameter measurements will be taken again after the make up has dried for 10 minutes, then the makeup/soil will be removed. The standard washing procedure used to remove the make-up/soil is a 30 second wash with 0.5 cc of a liquid product with a 15 second rinse under running water using a suitable constant temperature (e.g. 35 C) . When a towelette product is being used, the towelette is rubbed over the test site in a circular motion for 15 seconds. Final Chromameter measurement will be taken after the make- up/soil has been removed. This procedure may be performed twice a J6959 (C) CT - 59 - day for a period of up to 3 days. In repeat application, studies visual assessments will be made for dryness and erythema using the standard visual grading scale as described above.
f) Skin smoothness In this test the cleansing phase is tested outside of the razor head. Skin smoothness is evaluated (clinically) via Primos (in-vivo optical skin topography measuring device supplied by GFM Esstezhnik GmbH, Berlin, Germany) . Baseline roughness is measured (on leg/arms - starting dryness around grade 1-2) . For wash, bar rubbed on skin for 30 secs and the lather left on for 90 secs, rinsed for 30 secs at 35 C. Measure again the roughness 30 minutes after wash process. This procedure may be performed twice a day for a period of up to 5 days.
Smoothness is defined as the mean decrease in roughness at end of study period. Alternately skin smoothness can also be evaluated in a consumer test as follows.
The consumer test protocol consists of: 1) Recruiting aprox. 10-20 women in the age group of 25-65 and who are complexion bar users.
2) Use test and comparative products for a week each.
Half the panellists would use the test product first, and the other half would use the comparative product first.
J6959 (C) CT - 60 - 3) At the end of the test, the panellists rate their preference (on a 0-5 point scale) on the attribute of "Skin feels smoother".
Smoothness is defined as the consumer rating on the 0-5 point scale.
g) Skin softness In this test the cleansing phase is tested outside of the razor head. Skin softness may be evaluated using the Linear Skin Rheometer (Goodyear Scientific Instruments, UK) . Exfoliated skin has less dry flakes - hence is more soft/less stiff. The test involves baseline skin rheometer readings (on the leg/arms) to measure the dynamic spring constant (mgf/mm) of skin which is related to skin stiffness/softness. For wash, the bar is rubbed on the skin for 30 seconds and the lather left on for 90 seconds, rinsed for 30 seconds (at a suitable temperature e.g. 35 C), and the skin is gently pat dry. Next measure skin stiffness/softness 30 minutes after wash. This procedure may be performed twice a day for a period of up to 5 days. Softness is defined as the mean decrease in dynamic spring constant during the study period observed during the study period.
Alternately skin softness can also be evaluated in a consumer test as follows: The test protocol consists of: J6959 (C) CT - 61 - 1) Recruiting approx. 10-20 women in the age group of 25-65 and who are complexion bar users.
2) Use test and comparative products for a week each.
Half the panellists would use the test product first and the other half would use the comparative product first.
3) At the end of the test, the panellists rate their preference (on a 0-5 point scale) on the attribute of "Skin feels softer.
Softness is defined as the consumer rating on the 0- point scale h) pH test method Form an aqueous slurry by blending 10 grams of the cleansing phase formula with 90 g of water to create a 10 % slurry. The pH of the slurry is then measured at 25 C.
i) Zein test method The cleansing base of the inventive razor head preferably have zein solubility's of under about 50, 40, 30, and most preferably under about 25 using the zein solubility method set forth below. The lower the zein score, the milder the product is considered to be. This method involves measuring the solubility of zein (corn protein) in cleansing base solutions as follows: 0.3 g of cleansing base and 29.7 g of water are mixed thoroughly. To this is added 1.5 g of zein, and mixed J6959 (C) CT - 62 - f or 1 hour. The mixture is then centrifuged for 30 minutes at 3000 rpm. After centrifugation, the pellet is extracted, washed with water, and dried in a vacuum oven for 24 hours until substantially all the water has evaporated. The weight of the dried pellet is measured and percent zein solubilized is calculated using the following equation: % Zein solubilized = 100 (1-weight of dried pellet/l.5) The % Zein is further described in the following references: E. Gotte, Skin compatibility of tensides measured by their capacity for dissolving zein protein, Proc. IV International Congress of Surface Active Substances, Brussels, 1964, pp 83-90.
j) Solid cleansing phase mass sensory exfoliation index For this test, the cleansing phase is tested outside of the razor head. The cleansing phase sensory exfoliation index is determined using the following procedure.
The user takes the solid cleansing phase mass in one hand and rotates it under running water at 35 C. The number of rotations required for the exfoliant to be perceived (i.e. by tactile sensation) by the user is recorded. The solid cleansing phase mass exfoliation index is defined as the mean number of rotations required to perceive the exfoliant particles in the solid cleansing phase mass.
J6959 (C) CT - 63 - k) General Consumer Test Protocol For this test, the cleansing phase is tested outside of the razor head. The test protocol consists of: 1) Recruiting approx. 10-20 women in the age group of 25-65 and who are complexion bar users.
2) Use test and comparative cleansing phase products for a week each. Half the panellists would use the test product first and the other half would use the comparative product first.
3) At the end of the test, the panellists rate their preference on a 0-5 point scale for the following attributes: Exfoliates Provides Gentle Exfoliation Mositurizes and exfoliates Skin feels softer Skin feels smoother Is good for dry skin 1) Flex wash test method The samples are tested outside the razor heads. The study consists of three supervised daily washes in the morning (one hour apart) for three consecutive days of panel test subjects. Lather is applied to pre-moistened sponges by stroking them across wet sample bars ten times. Panellists wash their inner flex areas (inner arm between the wrist and elbow) in an elliptical motion J6959 (C) CT - 64 - for one minute, rinse, and pat dry. The test areas are evaluated for erythema at baseline, prior to each wash, and three hours after the third wash on each day.
Visual grading is conducted using a five-point scale for erythema. The scale in table C is used with values that range from 0 (none) to 4 (severe) with 2 being the test endpoint score.at which point the test for that particular panellist is discontinued. The visual grading data is analyzed using the Wilcoxon Signed Rank procedure.
m) Mush test This test is used for the solid cleansing phase tested outside of the razor head. Shave the solid cleansing phase mass to the dimensions of 7cm x 4cm x 2cm and carve a line halfway down the center of the solid cleansing phase mass (at the 3.5 cm mark) . Measure the weight of the solid cleansing phase mass. Suspend half of the solid cleansing phase mass (3.5 cm) in deionized water for 2 hours at a temperature of 25 C. After this time, lift up the solid cleansing phase mass and remove excess water by suspending the solid cleansing phase mass for 30 seconds, then weigh the solid cleansing phase mass. This is the weight of the solid cleansing phase mass, the mush, and the absorbed water.
After weighing, lightly scrape off the mush from the solid cleansing phase mass, being careful not to scrape off excess solid cleansing phase mass material that is not mush. Discard the mush and let the solid cleansing J6959 (C) CT - 65 - phase mass dry f or 12 hours. Weigh the final dry solid cleansing phase mass and the difference of the initial dry solid cleansing phase mass and the final dry solid cleansing phase mass, calculated for the 50 cm2 solid cleansing phase mass surface area, is the amount of mush (grams) . The difference in weight of the soaked solid cleansing phase mass and the initial dry solid cleansing phase mass is the amount of water absorbed.
The Mush Factor is defined as the ratio of the mush/50 cm2 of a given solid cleansing phase mass to a control mild isethionate solid cleansing phase mass mush/SO cm2 or in the present case, formula E provided above. For example, the mush of the inventive solid cleansing phase mass (formula A) is 6.2g mush/SO cm2, and the mush of formula E is 10.1 g mush/50 cm2 to provide a Mush Factor of 0.61.
n) Wear rate method This test is used for the solid cleansing phase tested outside of the razor head.
Weigh the solid cleansing phase mass to be tested. Set up an 8 liter bucket with continuous water running through it at 40.5 C. Immerse the solid cleansing phase mass and rotate it in the hands 20 times. Repeat.
Immerse the solid cleansing phase mass again to remove adhering lather, and let dry in the air at 25 C and approximately 50 % RH in a dish. Repeat every two hours J6959 (C) CT - 66 - over an 8 hour span. Let dry f or 12 hours at 25 C and approximately 50 % RH in a dish, and repeat for another 8 hour span.
Add 10 g of deionized water to the dish between immersions, and while the solid cleansing phase mass is resting in the dish, (this should be additive over the 8-hour span - meaning that after the first 2 hours lOg water are added to the dish; after 4 hours, add 10 grams more, totaling 20 grams water in the dish. After 6 hours, add 10 grams more, totaling 30g water in the dish, and so on for the 8-hour period, then let dry for 12 hours. The weight of the solid cleansing phase mass after 12 hours isrecorded and the wear rate is the percent weight loss of the solid cleansing phase mass.
o) Kraf ft point determination Make up a 10 % by wt. solution of surfactant or other sample in water. If needed, heat the system to dissolve the sample completely. Transfer the clear solution to a glass test tube. Place the test tube in a beaker equipped with a stirrer and filled with sufficient water to evenly cool the surfactant or sample solution. The solution should be cooled with continuous stirring and the temperature should be continuously recorded. Note the temperature when the crystallization process begins such that the solution becomes turbid. This temperature is taken as the Krafft point. If the crystallization temperature is below room temperature, add ice to the J6959 (C) CT - 67 beaker to cool the test tube below room temperature to measure the subambient Krafft point.
p) Method for calculation of yield stress with cheese cutter device This test is used for the solid cleansing phase tested outside of the razor head. An approximate value for yield stress can be determined by the cheese cutter method. The principle of the measurement is that a wire penetrating into a material with a constant force will come to rest when the force on the wire due to stress balances the weight. The force balance is: weight driving wire = force on wire due to material stress m g = K ys 1 D where m = mass driving wire (actual mass used in calculation is the mass placed on the device plus the weight of the arm which adds to the extra weight on the sample) g = gravitational constant, 9.8 rn/sec2 ys = yield stress 1 = length of penetration of wire into soap after 1 minute (mm) D = diameter of wire (mm) K = a geometrical constant The final equation is: J6959 (C) CT - 68 - ys = (3/8) m g 1(1 D) Procedure Cut a square of solid cleansing phase and position on the yield stress device. Place a mass on the yield stress device while holding the arm. 400g is an appropriate mass, although less might be needed for a very soft material. Gently lower the arm so the wire just touches the soap and let the arm go. Stop the vertical motion of the arm after one minute, and push the soap through the wire horizontally to cut a wedge out of the sample. Take the mass off the device and then measure the length of the cut in the sample. The wire would continue to cut the soap at a slow rate, but the length of the cut made by the wire in one minute is taken as the final value. Measure the temperature of the soap while the test proceeds.
Sample calculation: A 400 gram weight is used on the yield stress device and a 22 mm slice is measured where the wire has cut the solid cleansing phase after 1 minute. Assuming the diameter of the wire is 0.6 mm, the approximate yield stress iS: (3/8) (400+56) [g]9.8[m/sec2]103[kg/gI= 1.3105Pa or l3OkPa -6 2 2 22 [mm] 0.6 [mm] 10 [m /mm 1 J6959 (C) CT - 69 Optionally an Instron testing device (supplied by Instron Co., Boston, MA) may be used instead of a weight to apply stress to the wire contacting the solid cleansing phase mass.
q) Viscosity Measurement Scope This method is suitable for the measurement of the viscosity of the liquid or flowable cleansing composition.
Apparatus
Brookfield Cone and Plate DV-II+ Viscometer:;
Spindle S41; Procedure 1. Turn on Water Bath attached to the sample cup of the viscometer. Make sure that it is set for 25 C.
Allow temperature readout to stabilize at 25 C before proceeding.
2. With the power to the viscometer off, remove the spindle (S41) by turning counterclockwise.
3. Turn the power on and press any key as requested to autozero the viscometer.
J6959 (C) CT - 70 - 4. When the autozero function is complete, replace the spindle (turning clockwise) and press any key.
5. Attach the sample cup. Using the up/down arrow keys, slowly change the speed to 10 rpm and press the SET SPEED key. Use the SELECT DISPLAY key so that the display is in % mode.
6. Turn the motor on. If the display jumps to 0.4 % or higher or will not settle to 0 0.1 %, turn the adjustment ring clockwise until it does.
7. Rotate the adjustment ring counterclockwise until the reading is fluctuating between 0.0 and 1.0 %.
The fluctuation must occur approximately every 6 seconds.
8. Turn the adjustment ring clockwise exactly the width of one division from the setting reached in step 7.
9. Turn the motor off. Using the up/down arrow keys, slowly change the speed to 0.5 rpm and press the SET SPEED key. Use the SELECT DISPLAY so that the display is in cP.
J6959 (C) CT - 71 - 10. Place 2 0.lg of product to be measured into the sample cup. Attach the cup to the viscometer.
11. Allow the product to remain in the cup with the motor OFF for 2 minutes.
12. Turn the motor ON and allow the spindle to turn for 2 minutes before noting the reading on the display.
While this invention has been described with respect to particular embodiments thereof, it is apparent that numerous other forms and modifications of the invention will be obvious to those skilled in the art. The appended claims and this invention generally should be construed to cover all such obvious forms and modifications which are within the true spirit and scope of the present invention.
Claims (19)
1. A razor head for personal shaving, comprising: a) at least one blade member; b) a first skin engaging portion effectively positioned adjacent to the at least one blade for treating the skin of a user in advance of or simultaneously with the blade member contacting the skin of a user, the portion including and/or fluidly communicating with a mild cleansing base; and c) wherein the cleansing base includes at least one surfactant selected from C8 - C18 acyl isethionate(s)
2. The razor head of claim 1, further comprising a second skin engaging portion effectively positioned adjacent to the at least one blade member for treating the skin of a user subsequent to and/or simultaneously with the blade member contacting the skin of a user, the portion including and/or fluidly communicating with an after shave base.
3. The razor head of claim 1 or claim 2, wherein the at least one blade member and the cleansing base are situated within a single frame or in a plurality of frames positioned substantially adjacent to each other.
4. The razor head of any one of the preceding claims, wherein the cleansing phase has a zein value of less than 50.
J6959 (C) CT - 73 -
5. The razor head of any one of the preceding claims, wherein the isethionate surfactants are present in a total concentration of 1 to 60 % by wt.
6. The razor head of any one of the preceding claims, wherein the cleansing phase includes one or more hydrophillic and/or hydrophobic skin conditioning compounds in a total concentration range of 1 to 60 % by wt.
7. The razor head of any one of the preceding claims, wherein the cleansing phase is in the form of a solid having a yield stress value from 20 Kpa to 400 KPa at 25 C and 50 % RH.
8. The razor head of claim 7, wherein the isethionate surfactant has a Krafft point of 20 C or greater.
9. The razor head of any one of the preceding claims, wherein the cleansing phase contains an effective concentration of at least one compound selected from anti-acne actives, anti-wrinkle and anti-skin atrophy actives, skin barrier repair aids, cosmetic soothing aids, topical anesthetics, artificial tanning agents and accelerators, skin lightening actives, antimicrobial and antifungal actives, sunscreen actives, sebum stimulators, sebum inhibitors, antiperspirants and anti- glycation actives, or mixtures thereof.
10. The razor head of any one of claims 2 to 9, wherein the after shave phase contains an effective concentration of J6959 (C) CT - 74 - at least one compound selected from anti-acne actives, anti-wrinkle and anti-skin atrophy actives, skin barrier repair aids, cosmetic soothing aids, topical anesthetics, artificial tanning agents and accelerators, skin lightening actives, antimicrobial and antifungal actives, sunscreen actives, sebum stimulators, sebum inhibitors, antiperspirants or anti- glycation actives, or mixtures thereof.
11. The razor head of any one of the preceding claims, wherein the cleansing phase is in the form of a flowable liquid have a viscosity range of 100 to 2000 cps at 25 C as measured using a rotary viscometer.
12. The razor head of any one of claims 2 to 11, wherein the after shave phase is in the form of a flowable liquid have a viscosity range of 100 to 2000 cps at 25 C as measured using a rotary viscometer.
13. The razor head of claim 11 or claim 12, further comprising potassium and/or sodium acyl isethionate.
14. The razor head of claim 13, wherein potassium and/or sodium acyl isethionate has 1 to 10 moles of ethoxylation.
15. The razor head of any one of claims 12 to 14, wherein potassium and/or sodium isethionate is present at a concentration range of 3 to 15 % by weight.
J6959 (C) CT - 75 -
16. The razor head of any one of claims 5 to 15, wherein the moisturizer is selected from fatty acids, glyceride oil, mineral oil, petrolatum, glycerin, polyethylene glycol, or blends thereof.
17. The razor head of any one of the preceding claims, wherein the bar provides an aqueous slurry pH of 4 to 8.
18. The razor head of any one of the preceding claims, further comprising less than 10 % by wt. of soluble soap.
19. A method for simultaneously shaving and moisturizing the skin with a razor comprising the steps of: a) providing a razor head including a cleansing base comprising about 1 % to 60 % by wt. of one or more surfactants selected from C8 - Cl8 acyl isethionate(s) and about 1 % to 60 % by wt. of skin conditioning agent(s); b) adding sufficient water to wet the cleansing base and the skin; c) applying the razor head to the skin; and d) moving the razor head across the skin to remove hair and coat the underlying skin with the skin conditioning agent (s).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2006/002959 WO2006108522A1 (en) | 2005-04-12 | 2006-03-23 | Razor head with mild cleansing composition as a shaving aid |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0610883D0 GB0610883D0 (en) | 2006-07-12 |
GB2423494A true GB2423494A (en) | 2006-08-30 |
Family
ID=36694808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0610883A Withdrawn GB2423494A (en) | 2006-03-23 | 2006-03-23 | Razor head including acyl isethionate surfactant dispenser |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2423494A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2431580A (en) * | 2005-10-28 | 2007-05-02 | Unilever Plc | Deodorant composition containing polyethylene glycol humectant |
WO2011103072A1 (en) * | 2010-02-18 | 2011-08-25 | The Gillette Company | Hair removal device comprising moisturizing compositions |
EP2517693A1 (en) * | 2011-04-26 | 2012-10-31 | The Gillette Company | Hair removal device comprising a modifying surfactant |
EP2537511A1 (en) * | 2011-06-24 | 2012-12-26 | The Gillette Company | Hair removal device comprising erodable moisturizer |
WO2018005148A1 (en) * | 2016-06-30 | 2018-01-04 | The Gillette Company Llc | Shaving aid for razor cartridges comprising filaments |
WO2018005574A1 (en) * | 2016-06-30 | 2018-01-04 | The Gillette Company Llc | Shaving aid for razor cartridges comprising a nano-filament |
US10773405B2 (en) | 2016-06-30 | 2020-09-15 | The Gillette Company Llc | Shaving aid for razor cartridges comprising a nano-filament comprising a core and sheath |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB470918A (en) * | 1935-11-22 | 1937-08-23 | Wolf Kritchevsky | Shaving cream |
GB2138438A (en) * | 1983-04-20 | 1984-10-24 | George Herman Michel | Shaving composition |
US5056221A (en) * | 1987-12-19 | 1991-10-15 | Wilkinson Sword Gmbh | Razor and process for manufacturing a surface of low frictional resistance on a razor |
WO2000010780A1 (en) * | 1998-08-19 | 2000-03-02 | The Gillette Company | Applying fluid preparations to the skin, e.g. in connection with shaving |
WO2003009823A2 (en) * | 2001-07-26 | 2003-02-06 | The Gillette Company | Non-aerosol shaving gel |
WO2004017785A2 (en) * | 2002-08-21 | 2004-03-04 | Eveready Battery Company, Inc. | Razor having a microfluidic shaving aid delivery system and method of ejecting shaving aid |
-
2006
- 2006-03-23 GB GB0610883A patent/GB2423494A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB470918A (en) * | 1935-11-22 | 1937-08-23 | Wolf Kritchevsky | Shaving cream |
GB2138438A (en) * | 1983-04-20 | 1984-10-24 | George Herman Michel | Shaving composition |
US5056221A (en) * | 1987-12-19 | 1991-10-15 | Wilkinson Sword Gmbh | Razor and process for manufacturing a surface of low frictional resistance on a razor |
WO2000010780A1 (en) * | 1998-08-19 | 2000-03-02 | The Gillette Company | Applying fluid preparations to the skin, e.g. in connection with shaving |
WO2003009823A2 (en) * | 2001-07-26 | 2003-02-06 | The Gillette Company | Non-aerosol shaving gel |
WO2004017785A2 (en) * | 2002-08-21 | 2004-03-04 | Eveready Battery Company, Inc. | Razor having a microfluidic shaving aid delivery system and method of ejecting shaving aid |
Non-Patent Citations (1)
Title |
---|
IPC7 Section B * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006308228B2 (en) * | 2005-10-28 | 2010-05-20 | Unilever Global Ip Limited | Antiperspirant or deodorant compositions |
GB2431580A (en) * | 2005-10-28 | 2007-05-02 | Unilever Plc | Deodorant composition containing polyethylene glycol humectant |
WO2011103072A1 (en) * | 2010-02-18 | 2011-08-25 | The Gillette Company | Hair removal device comprising moisturizing compositions |
EP2361607A1 (en) | 2010-02-18 | 2011-08-31 | The Gillette Company | Hair removal device comprising moisturizing compositions |
CN102762192A (en) * | 2010-02-18 | 2012-10-31 | 吉列公司 | Hair removal device comprising moisturizing compositions |
CN103491939A (en) * | 2011-04-26 | 2014-01-01 | 吉列公司 | Hair removal device comprising a modifying surfuctant |
EP2517693A1 (en) * | 2011-04-26 | 2012-10-31 | The Gillette Company | Hair removal device comprising a modifying surfactant |
WO2012148939A3 (en) * | 2011-04-26 | 2013-03-07 | The Gillette Company | Hair removal device comprising a modifying surfuctant |
RU2589821C2 (en) * | 2011-06-24 | 2016-07-10 | Дзе Жиллетт Компани | Device for hair removal, comprising consumable moisturiser |
WO2012177979A3 (en) * | 2011-06-24 | 2013-04-18 | The Gillette Company | Hair removal device comprising erodable moisturizer |
EP2537511A1 (en) * | 2011-06-24 | 2012-12-26 | The Gillette Company | Hair removal device comprising erodable moisturizer |
EP2537511B1 (en) | 2011-06-24 | 2017-02-01 | The Gillette Company LLC | Hair removal device comprising erodable moisturizer |
WO2018005148A1 (en) * | 2016-06-30 | 2018-01-04 | The Gillette Company Llc | Shaving aid for razor cartridges comprising filaments |
WO2018005574A1 (en) * | 2016-06-30 | 2018-01-04 | The Gillette Company Llc | Shaving aid for razor cartridges comprising a nano-filament |
CN109219430A (en) * | 2016-06-30 | 2019-01-15 | 吉列有限责任公司 | The shaving aid for razor cartridge comprising long filament |
CN109310584A (en) * | 2016-06-30 | 2019-02-05 | 吉列有限责任公司 | The shaving aid for razor cartridge comprising nanowire filament |
AU2017289964B2 (en) * | 2016-06-30 | 2020-04-30 | The Gillette Company Llc | Shaving aid for razor cartridges comprising a nano-filament |
US10773405B2 (en) | 2016-06-30 | 2020-09-15 | The Gillette Company Llc | Shaving aid for razor cartridges comprising a nano-filament comprising a core and sheath |
US11020865B2 (en) | 2016-06-30 | 2021-06-01 | The Gillette Company Llc | Shaving aid for razor cartridges comprising a nano-filament |
CN109310584B (en) * | 2016-06-30 | 2022-03-22 | 吉列有限责任公司 | Shaving aid for razor cartridges comprising nanofilaments |
Also Published As
Publication number | Publication date |
---|---|
GB0610883D0 (en) | 2006-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1868778B1 (en) | Razor head with mild cleansing composition as a shaving aid | |
AU2003250946B2 (en) | Toilet bar having simultaneous exfoliating and moisturizing properties | |
US20050084470A1 (en) | Skin care and cleansing compositions containing oil seed product | |
EP1523606A1 (en) | Method for completing injection wells | |
GB2423494A (en) | Razor head including acyl isethionate surfactant dispenser | |
AU2004294296B2 (en) | Massaging toilet bar with disintegrable agglomerates | |
CA2696420C (en) | Mild acyl isethionate toilet bar composition | |
EP1805288B1 (en) | Mild acyl isethionate toilet bar composition | |
US20060002883A1 (en) | Mild synthetic detergent toilet bar composition | |
US7109154B2 (en) | Combination toilet bar composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |